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Over the last three decades, solid-phase microextraction (SPME) has continuously evolved 
and received recognition as a useful tool in various scientific fields. Notable applications have been 
published including environmental analysis, in vivo drug monitoring, direct coupling to mass 
spectrometers, and analysis of complex biological samples such as tissue matrix, etc. Much of this 
success stems from the intrinsic simplicity of SPME’s use, variable configurational geometry to 
promote experimental suitability, and most prominently, the ability to extract target analytes 
selectively via the free concentration.  However, the theory and concept of SPME are much more 
complex than its simple practical handling. Rigorous fundamental and experimental studies are 
required before optimizing SPME to facilitate the simplification of many analytical applications. 
Computational models are required to reduce the extent of experimental studies and refine 
theoretical concepts. In this regard, numerical models have been increasingly used in SPME over 
the last six years. In particular, understanding how the mass transfer is controlled by the thickness 
of the extraction phase, the shape of the SPME device, and the important effect of the presence 
of binding matrices in samples. In this thesis, computational models were developed to 
demonstrate how binding matrices contribute to the mass transfer of analytes to the SPME 
extraction phase.  
Chapter 1 provides an overview of matrix components, SPME, and the use of 
computational modeling. Chapter 2 describes the SPME mass transfer kinetics in the biological 
tissue matrix. The anticancer drug doxorubicin (DOX) was chosen as a model for this study. Its 
activity is controlled by the free concentration in the extracellular space that crosses the cell 
membrane to bind with a specific receptor. However, the distribution of DOX in the tissue matrix 
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is very dynamic as it binds heavily with human serum albumin (HSA), cell membrane, and other 
macromolecules. It is cleared from the body through renal excretion. Therefore, the total 
concentration measurement followed by conventional analytical methods does not represent the 
bioactivity of DOX in the tissue matrix. Accordingly, a suitable analytical technique was developed 
for the determination of the free in situ concentration of DOX in the extracellular space where it 
is bound to multiple binding matrix components. Commercially available mixed-mode bio-SPME 
fibers using coating consisting of C8 and weak cation exchange (WCX) materials were used to 
extract DOX via the free form from a surrogate tissue matrix – bovine lung tissue. Computational 
models were developed to determine the mass transfer of DOX during extraction and how binding 
matrices control the distribution of DOX in the tissue matrix as well as the mass transfer onto the 
extraction phase. The investigations revealed that DOX is 99.97% bound to the tissue matrix, with 
its free concentration profoundly depleted in the extracellular space. The free concentration was 
not affected by the mass transfer to the extraction phase due to instant release from binding 
matrices, which indicated that binding matrices serve as a reservoir of DOX. 3D computational 
models were developed in COMSOL Multiphysics based on experimentally obtained physical 
parameters and available literature values to demonstrate the mass transfer between different 
reservoirs in the tissue matrix. The development of computational models involved experiment-
based simulation of DOX extraction in matrix-free solid medium (agar gel) at static conditions, 
followed by extraction of DOX spiked in PBS solution to demonstrate how convection contributes 
to the mass transfer. Finally, a computational model was developed to demonstrate the effect of 
the HSA binding matrix on the mass transfer of DOX under agitation conditions. Results showed 
that mass transfer in tissue was faster than during extraction from even agitated PBS solution 
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without HSA binding matrix, implying that binding matrix contributes to the mass transfer through 
releasing bound analyte within the boundary layer. Furthermore, a computational model was 
developed to demonstrate the mass transfer in the tissue matrix. The results showed that mass 
transfer in tissue is profoundly faster than agitated extraction in PBS solution with HSA binding 
matrix, even though it takes place in static conditions.  This study demonstrated how the binding 
matrix controls the mass transfer and distribution of free analyte that is of interest to quantitative 
pharmacokinetics and pharmacodynamics.  
  
 In Chapter 3, SPME was used to investigate the complex binding equilibrium between fatty 
acids (FA) and HSA. HSA is the main cargo molecule for FAs in the human body and in normal 
physiological conditions, almost 99% of FAs are bound to it. HSA has multiple FA binding sites, 
which are heterogeneously distributed in three structurally similar domains of HSA. The affinities 
of these binding sites are not identical, which results in multiple binding equilibria with FAs, 
dependent on the ligands’ initial concentration. The binding characteristics of FAs with HSA could 
be altered by the allosteric modification which is related to important pathological information. 
The requirement of accurate measurement of free FAs has been fulfilled in this study by SPME, 
due to the technique’s capability to determine the free concentration in complex matrices. Both 
site-oriented and stoichiometric approaches were used to analyze the binding characteristics. 
Computational models were developed to demonstrate the mass transfer kinetics of FA within the 
HSA binding matrix. The apparent binding constant of FAs to HSA was determined followed by a 
Scatchard plot and used to simulate the extraction kinetics of FAs. In-silico results demonstrated 
good fitting with experimental data, which indicates the reliability of this method. Also, 
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stoichiometric binding constants were determined using a nonlinear least-square regression 
model.  
The overall work reported in this thesis reflects on experimental and computational 
approaches of SPME techniques to measure the mass transfer of free analyte from complex 
matrices where the analyte is involved in multiphase equilibria with binding components that 
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Chapter 1 Introduction 
1.1. An overview of blood plasma and tissue components 
Blood plasma is the acellular fraction of whole blood which looks light yellowish in color. It is 
obtained by adding an anticoagulant to whole blood and then removing the blood cells (RBC, 
WBC, and platelets) by centrifugation (Figure 1). It is the liquid part of whole blood which makes 
up to 55% of total blood volume. It contains 90-92% water and 7-8% of solid ingredients and <1% 
dissolved gases. Solid components of plasma can be categorized broadly into two groups- large 
and small molecules. Among large molecules most notable are plasma proteins such as serum 
albumin (50-60%), immunoglobulins (35-38%), enzymes, and some hormones, etc. Among small 
molecules, glucose, lipids, amino acids, neurotransmitters, electrolytes, drug metabolites, 
nutrients, etc.1,2,3 Beside plasma another important derivative of blood is serum, which is 
obtained by coagulation of blood followed by centrifugation. In other words, the serum is the 
fluid part of the plasma which is basically without fibrinogen - a key blood coagulation factor.  
 
Figure 1. 1 A schematic diagram of whole blood and plasma 
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The plasma essentially serves as the transport medium which carries all the nutrients to the 
cells, and it also maintains the intravascular osmotic pressure that controls the balance of 
electrolytes.4 Plasma contains numerous different components with a wide dynamic range of 
abundance. The most abundant plasma component is the human serum albumin (HSA), a large 
protein (585 amino acid residues) that serves as a transport vehicle for many small molecules 
including fatty acids, amino acids, bilirubin, hemin, drugs, etc.5 It binds small molecules through 
specific or nonspecific interactions and carries them to their respective site of action. Therefore, 
it works as a reservoir for many small molecules (drugs and fatty acids for example) and plays a 
vital role by maintaining their bioactive concentrations.6 Characterization of the binding 
interaction of drug molecules with albumin is of paramount interest in clinical research for drug 
development. The binding interaction of analytes with HSA will be described in detail later in 
chapter 2 and chapter 3. 
On the other hand, biological tissue is a complex network structure that is composed of 
three basic components: cells, extracellular matrix (ECM), and signaling components.7 From the 
analytical standpoint adopted in this study, only extracellular matrix components will be 
discussed here.  ECM is a three-dimensional dynamic cross-linked network that is composed of 
minerals and macromolecules, such as collagen, glycoproteins, polysaccharides, drug molecules, 
etc. ECM provides physical and mechanical support to the tissue. It regulates all cellular functions 
such as cell growth, cell proliferation, cell differentiation, and cell homeostasis, etc. All necessary 
components to maintain cellular functions are available in ECM. However, ECM components are 
highly dynamic due to continuous cellular processes.8,9 Therefore, ECM components can provide 
valuable information on many biological functions. This requires appropriate analytical 
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techniques to investigate with minimal invasion of the native environment. Chapter 2 will 
describe detailed ideal analytical techniques to characterize ECM components. 
1.2. Characterization of plasma components: impact of binding matrices 
Blood plasma is the most widely used analytical sample in many biological research fields. Since 
plasma contains plenty of components that play key roles in cellular and physiological activities 
such as metabolic reactions and cell signaling, identification and characterization of these 
components are of great interest in biomedical research fields. For example, characterization of 
regulatory proteins (enzymes, hormones, etc.) provides information about intra and extracellular 
reaction pathways, identification of biomarkers is necessary for disease prognosis and diagnosis, 
characterization of drug molecules and their metabolites is required for pharmacokinetic (PK) 
and pharmacodynamic (PD) studies in clinical research, and characterization of illicit drugs and 
poisons in forensic and toxicological studies, etc.10–16  
Since blood plasma is one of the most complex biological sample matrices, most often 
characterizations require very sophisticated and tedious analytical techniques to attain accurate 
information. Due to the presence of a wide range of components with highly variably abundance, 
separation of low abundant components from the matrix is tremendously challenging – yet it is 
crucial for quantification.3 In the case of small molecules, the characterization is made difficult 
by the presence of highly abundant binding matrices such as HSA. Of particular interest to this 
thesis are the cases in which the analytes are small molecules, which are heavily bound to the 
large matrix components - mostly serum albumin.  
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The extent of such binding interactions results in the perturbation of analytes into matrix-bound 
and unbound (free) states. The fraction of the analyte that remains unbound (free) participates in 
physiochemical reactions and is therefore considered the bioactive concentration. Most of the 
small drug molecules bind with HSA, and the measurement of free/bioactive concentration is an 
integral part of PK/PD studies in clinical research for drug development. In general, the abundance 
of binding components (such as HSA, immunoglobulins, etc.) in plasma is significantly higher than 
that of target analytes (such as pharmaceutical drugs). In such cases, the free analyte 
concentration predominantly depends on their binding affinities towards the matrix components. 
Analytes with higher nonpolar character (logP) show stronger binding affinity with matrix 
components.17,18 This active concentration is dynamic and subject to changes concerning 
physiological conditions.19 We can write the binding reaction between analyte and matrix 
component as follows:  
A + M <=> AM            (1.1) 
Where: A,  is the free analyte, M is the binding matrix component and AM is the matrix-bound 
analyte. At equilibrium the binding constant for this equilibrium can be defined by the following 
equation: 
𝐾 =  =  
[ ]
[ ] ∗[ ]
         (1.2) 
Where: 𝐾  is the binding association constant for the analyte A, 𝑘  and 𝑘  are the forward 
(matrix association) and backward (matrix dissociation) rate constants, [𝐴]  is the free unbound 
concentration of the analyte when equilibrium is established. This unbound state is the subject 
of many analytical studies since it represents the active (bioavailable) concentration that 
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participates in biological activities. 
1.3. Characterization of plasma components: analytical methods 
Most analytical process essentially includes three stages – sampling, sample preparation, and 
detection. Among these, sample preparation is the bottleneck of the whole analytical process 
because It is time consuming and tedious.20 Due to the complex nature of plasma, sample 
preparation requires multiple experimental steps- sample pretreatment, separation/extraction, 
sample clean-up, enrichment, and analyte transfer to a detection device, such as liquid 
chromatography coupled with mass spectrometry (LC-MS). The most popular sample preparation 
techniques used for plasma components analysis are - liquid-liquid extraction (LLE), solid-phase 
extraction (SPE), dispersive solid-phase extraction (dSPE), membrane-based separations, such as 
ultrafiltration (UF) and microdialysis (MD), etc.21 LLE uses organic solvents to extract or isolate the 
target analytes, which partition between aqueous and organic phase. For example, extraction of 
fatty acids (FAs) from blood plasma according to the Bligh-Dyer (BD) method involves the addition 
of a mixture of chloroform-methanol (1:2). The separation takes place via partition between the 
aqueous and organic phases.22,23 The organic phase which is enriched with FAs due to their high 
partition coefficient is separated and then analyzed. SPE uses a solid sorbent for the extraction of 
a target analyte. The sorbent is packed in a small cartridge through which the sample containing 
analytes of interest is passed. The separation takes place based on the affinity of the analyte to 
the sorbent material.10 In dispersive SPE, the sorbent is dispersed into the sample matrix and 
separated from the matrix by centrifugation.24  While the separation in LLE, SPE, and dSPE involves 
exhaustive extraction, the membrane-based separation technique provides nonexhaustive 
extraction of analyte via free/unbound concentration. Both ultrafiltration and microdialysis use 
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porous membranes with a low molecular weight cut-off, allowing the permeation of small but not 
of large molecules. In addition, microdialysis permits in vivo analysis.25 Albeit microdialysis (MD) 
and ultrafiltration are capable of determining the free concentration, they possess several 
shortcomings; in particular, their application is limited molecules which are both polar and low 
molecular weight. The analysis is time consuming, and suffers from low recovery of solutes with 
low abundance.24,26 
1.4. SPME 
To overcome the limitations of traditional sample preparation methods for separating 
free/unbound analytes from complex biofluids like plasma sample, researchers around the world 
endeavored to innovate new sample preparation tools that can mitigate the complexities 
associated with existing techniques. With that mindset a researcher might aim to develop such a 
novel technique which will be facile, faster, nonexhaustive, noninvasive and also nondestructive 
which means the sample can be reused. Moreover, such new methods might sample free 
concentration analyte only. However, no analytical technique can meet all requirements and each 
analytical technique has its strength and weakness. Nonetheless the best choice would be the one 
which meets most of the requirements. Such and endeavor was made by Arthur and Pawliszyn in 
1990 with the invention of a microextraction device named as solid-phase microextraction 
(SPME).20 SPME is a nonexhaustive, noninvasive and solvent free (sample matrix does not require 
organic solvent) sample preparation technique that extracts analytes via free concentration. SPME 
is able to integrate both sampling and sample preparation steps through development of in vivo 
sample extraction.21 The recent advancement of SPME directly to mass spectrometry, has further 
reduced the time and cost of analysis.27–29  Although SPME demonstrated great advantages over 
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traditional sample preparation techniques in many cases, particularly extraction of small 
molecules from complex biological samples, it is still limited with respect to large molecules; 
applications to the latter is still at the stage of exploration.30 
1.5. General aspects of solid-phase microextraction (SPME) 
Solid-phase microextraction (SPME) is a separation technique developed by Arthur and Pawliszyn 
in 1990,31 which includes a micro extraction device to selectively separate the analytes of interest 
from sample matrices via negligible depletion of free concentration. The extraction device consists 
of small volume/amount of sorbent (extraction phase) which is essentially a semi-liquid 
(absorptive) or solid (adsorptive) material such as polydimethylsiloxane (PDMS), C8, C18, 
carbowax (CW), etc. coated onto a solid support. The rate of mass transfer of analytes is controlled 
by the diffusion to the boundary layer (Figure 1.2) which is theoretically treated as a stagnant layer 
of sample matrix. The thickness of the boundary layer can be minimized by applying convection to 
the sample matrix.20 The diffusion of analyte in the extraction phase is insignificant compared to 
the thickness of the coating. SPME is an equilibrium based non-exhaustive extraction technique 
where the analyte of interest partitions (for absorptive coating such as PDMS) between sample 
matrix and extraction phase. At equilibrium the distribution of analyte can be expressed as:  




Figure 1. 2 Boundary layer model configuration of SPME extraction in pre-equilibrium stage 
demonstrating the mass transfer of analytes in different regions in terms of concentration versus 
distance profile 
Where: 𝐾  is the distribution constant at equilibrium also known as partition coefficient when the 
extraction phase is absorptive (semi-liquid such as PDMS), 𝐶  and 𝐶  are the concentrations of 
analyte in the extraction phase and sample matrix respectively. The amount of analyte extracted 
(𝑛 ) under equilibrium can be correlated with the concentration of analyte in the sample matrix 
by the following equation:  
𝑛 = 𝐶                        (1.4) 
Where: 𝑛  is the amount of analyte extracted at equilibrium, 𝑉  is the volume of extraction phase, 
𝑉  is the volume of the sample matrix and 𝐶  is the initial concentration of analyte in the sample 
matrix. Since the volume of the extraction phase, 𝑉   is significantly smaller than the sample 
volume 𝑉 , depletion of analyte from the sample matrix is negligible. Under these conditions, 𝑉 ≫
𝐾 𝑉 , and eq. (1.4) can be simplified into:  
𝑛 = 𝐾 𝑉 𝐶                 (1.5) 
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Eq. (1.5) demonstrates that the amount extracted (𝑛 ) is independent of sample volume 𝑉 , which 
makes it suitable quantitative technique where measurements of sample volume is difficult to 
determine such as in vivo experiments.  
1.6. Mass transfer in SPME 
The driving forces of mass transfer in SPME can be categorized into three factors- diffusion of the 
analyte in the bulk sample, convection, and matrix assisted mass transfer. The dynamics of mass 
transfer mechanism can be illustrated as follows: 
 
Figure 1. 3 A schematic diagram shows the factors that contribute to the analyte mass transfer in 
SPME process 
 
When an SPME device is immersed in an aqueous sample, mass transfer of the analyte takes place 
from bulk (high concentration) towards the extraction phase (low concentration) via diffusion in 
the absence of other external force (such as, convection or reaction). In that case the only driving 
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for mass transport is diffusion which can be described by Fick’s law. The time dependent mass 
balance equation  for diffusion controlled mass transport can be described as:32  
− ∇ ∗ (𝐷 ∇𝑐 ) = 0      (1.6) 
Where:  (mol m2 s-1) is the molar flux of the species (analyte in this case) 𝑖, 𝑐  (mol m-3) is the 
total free analyte concentration (not total initial concentration) in the sample matrix, 𝐷  (m2 s-1) is 
the diffusivity of analyte 𝑖 in the sample matrix.  
Under agitated condition, mass transport is controlled by both diffusion and convection. The mass 
balance equation for convective-diffusive mass transfer can be derived as:  
− ∇ ∗ (𝐷 ∇𝑐 ) + 𝒖 ∗ ∇𝑐 = 0    (1.7) 
Where:  𝒖 (m s-1) is the velocity field of analyte due to convection. When there is any reaction 
involved in the system, it also contributes to the overall mass transfer by consuming or producing 
analyte species in the system. In such case, the mass balance equation can be formulated as: 
− ∇ ∗ (𝐷 ∇𝑐 ) + 𝒖 ∗ ∇𝑐 = 𝑅                  (1.8) 
Where:  𝑅 is the source term which is the result of either generation or elimination of analyte 𝑖 in 
the system. In this case, 𝑅 corresponds to the matrix assisted mass transfer. The matrix 
components adjacent to the extraction phase (which are inside the boundary layer) release the 
bound analyte into the extraction phase due to high affinity of the extraction phase to the target 
analyte. Since the concentration of the binding matrix components is significantly higher than the 
concentration of free analyte, the contribution of matrix assisted mass transfer leads the 
extraction phase to reach equilibrium faster. Therefore 𝑅 > 0 in eq (1.8). The analyte is also 
transported from the extraction phase to the sample matrix. Since there is no convection in the 
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extraction phase, and ideally no matrix component is present in the extraction phase (SPME 
extraction phase is selective and restricts the access of binding matrices) the source term 𝑅 = 0. 
Therefore, the mass transfer is only governed by the diffusion. 
− ∇ ∗ (𝐷 ∇𝑐 ) = 0     (1.9) 
Where, 𝐷  is the diffusion coefficient of analyte in the extraction phase and 𝑐  is the analyte 
concentration in the extraction phase. 
1.7. Significance of the partition coefficient (𝑲𝒆𝒔 ) 
𝐾  is a crucial thermodynamic parameter for analyte under given extraction conditions which 
depends on mode of extraction (such as headspace or direct immersion), physicochemical 
properties of the extraction phase material, geometry of the SPME device as well as temperature 
and pH of the extraction conditions. In typical SPME terminology, 𝐾  refers to the affinity of the 
analyte towards the extraction phase for a given set of extraction conditions. In such case, the net 
mass transfer kinetics of the analyte can be expressed as:17 
 = 𝑘 𝐶 − 𝑘 𝐶         (1.10) 
Where: 𝐶  and 𝐶  and are the time dependent concentrations of the analyte in the sample matrix 
and extraction phase, respectively; 𝑘  and 𝑘  are the forward (uptake) and reverse (release) rate 
constants of analyte. At equilibrium 𝑘 𝐶 = 𝑘 𝐶 , therefore the net mass transfer equals zero and 
eq. (1.10) is reduced to: 
=  =  𝐾                     (1.11) 
Eq. (1.11) states the empirical formula to estimate 𝐾 . When the initial concentration of the 
analyte 𝐶  is known, one can simply derive the value of 𝐾  by measuring the value 𝐶  followed 
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by desorption, since 𝐶 =  𝐶 − 𝐶 . The higher the affinity of the analyte towards the extraction 
phase, the higher the 𝐶 value, and the resulting increased 𝐾  value requires longer extraction 
time for the analyte to reach equilibrium (Figure 1.4). Since 𝐾  is a thermodynamic constant, it is 
not affected by the presence of binding matrix components (such as humic materials in water, 
proteins and nucleic acids in blood plasma, etc.) in samples which are ubiquitous in most analytical 
samples. The reliance of measurements at equilibrium enables SPME technique to estimate the 
free analyte concentration in the presence of binding matrix components - one of the most 
exclusive SPME features that makes it unique and allows it to stand out amongst many 
contemporary sample preparation techniques.  
 
Figure 1. 4 Simulated SPME extraction profile generated by COMSOL Multiphysics using 
comprehensive physicochemical parameters demonstrates how K_esaffects the extraction time 
to reach equilibrium, provided all other experimental conditions are kept constant 
The ‘free’ concentration refers to the fraction of the analyte which is unbound to the sample 
matrix constituents and thus able to participate in the mass transfer through the boundary layer. 
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The binding matrices are usually suspended solids or macromolecules to which free analytes 
(which are assumed to be small molecules) bind. To acquire extraction via free analyte 
concentration, it is necessary to restrict the extraction of matrix macromolucules or matrix-bound 
analytes, which has been achieved by using biocompatible extraction phase (coated with PAN or 
Teflon binders). The biocompatibility is defined by the immunogenic or toxicological inertness of 
a material when placed in a biological system. For example, PAN coated SPME fiber demonstrated 
less interaction with biological matrix components like proteins or macromolecules.33 This 
increases the stability of the extraction phase, also produces better analytical results. One of the 
reasons for biocompatibility is the smoothness of the surface which is enhanced using PAN. 
Biocompatible coating also can be prepared using restricted access material (RAM) such as, alkyl-
diol-silica (ADS).34,35 
1.8. SPME kinetics and quantitation 
The fundamental aspects of SPME kinetics are necessary to understand for accurate quantitative 
analysis.  In defined extraction conditions, the amount of the analyte extracted (𝑛) over time (𝑡) 
can be expressed by the following equation:20 
𝑛 = (1 − 𝑒 ) 𝐶         (1.12) 
Where: 𝑎 is a rate constant which depends on the physical properties of the extraction phase, 
agitation, sample volume, mass transfer coefficient, and distribution coefficient. Eq. (1.12) can be 
simplified by combining with eq. (1.4): 
𝑛 = 𝑛 (1 − 𝑒 )                              (1.13)  




Figure 1. 5 Schematic SPME time profile with equations providing basis for quantitation at 
different kinetic regimes 
 
From a kinetic perspective, quantification of the analyte can be performed following two 
approaches - equilibrium extraction and pre-equilibrium extraction in the kinetic regime. 
Quantification using equilibrium extraction provides higher sensitivity and reproducibility, because 
the maximum possible partition of analyte is reached and the dynamic conditions (agitation) of 
the extraction process do not affect the amount extracted. The pre-equilibrium-based 
quantification is affected by the convection/agitation conditions. While equilibrium-based 
quantification method may be preferable for achieving better precision and accuracy, the major 
constraint of this method remains the time necessary to reach equilibrium. The equilibration time 
is defined as the time required to extract ≥95% of the amount that would be obtained at t = ∞. It 
can be calculated according to the equation 1.11:  
𝑡 ≈ 𝑡 % =                     (1.14) 
Where: 𝑏 is the extraction phase (coating) thickness, 𝛿 is the boundary layer thickness and 𝐷  is 
the diffusion coefficient of the analyte in the bulk sample. Eq. (1.14) indicates at the factors that 
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modulate the extraction equilibrium time (𝑡 ). Faster equilibration can be achieved by optimizing 
those parameters. For example, equilibrium time can be shortened by decreasing the coating 
thickness and increasing the agitation speed. To enhance the sensitivity it is necessary to increase 
the 𝐾  value, which can be achieved by using appropriate coating chemistry.   
1.9. The use of computational modeling in SPME  
Understanding of the fundamental concepts of SPME requires in-depth knowledge of physics, 
mathematics and thermodynamics. For example, the extraction kinetics or mass transfer of anlyte 
in SPME is influenced by the of partition coefficient (Figure 1.4), coating thickness, convection, and 
the presence of binding matrix components (Figure 1.6).17,18,26,36 
 
Figure 1. 6 Extraction of benzene using PDMS SPME fiber with different coating thickness (a), at 
different agitation speed (b), and effect of BSA (bovine serum albumin) binding matrix on pyrene 
extraction (c) 
 
Figure 1.6 (a) demonstrates how the extraction reaches equilibrium faster with decrease in 
coating thickness. This gives a valuable information to optimize coating thickness for specific 
experiments where the sample size is very small and agitation is difficult to perform for example 
biofluids. Figure 1.6 (b) shows how equilibrium reaches faster with agitation, and Figure 1.6 (c) 
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shows how the concentration of binding matrix component contributes to faster equilibrium time. 
Besides fundamental concepts, computational model can be used to understand some in-depth 
SPME concepts such as – radial diffusion and balanced coverage. The mass transfer of analyte is 
heavily depended on the geometry (size and shape) of SPME device. The mass flux increases 
significantly due to radial diffusion when the radius of the device is below 10 µm (Figure 1.7).36  
 
Figure 1. 7 Simulation of total flux for two different radii of circular coating surfaces (a) 100 µm 
and (b) 2 µm, and effect of radius length on total flux for different SPME geometries (c) 
 The radial diffusion of analyte plays a vital role to develop efficient miniaturized SPME 
geometries for many applications such as, SPME fiber tip for extraction in small volume, magnetic 
nanoparticles for dispersive extraction.37,38 Figure 1.7 (a) and (b) indicate the enhanced total flux 
induced by the smaller radius (2 µm) due to radial diffusion. While the Figure 1.7 (c) demonstrates 
how the radial diffusion is governed by the shape of the SPME device. The spherical geometry 
induces higher degree of radial diffusion compared to other geometries like cylindrical and flat 
membrane.  
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There are many SPME applications where extraction of multiple analytes in complex samples 
is essential for both quantitative and qualitative (metabolites) aspects. In this regard, appropriate 
SPME coating chemistry is required to attain a balanced coverage of analytes with wider range of 
properties.18 The ‘balanced coverage’ or distribution of analytes in the extraction phase heavily 
depends on the affinity of particular analyte to the extraction phase (partition coefficient, 𝐾 ) 
which can be optimized by changing the coating chemistry. Well known C-18 and PDMS extraction 
phases show higher affinity towards nonpolar analytes, whereas, ionic extraction phases show 
higher affinity towards polar analytes.  Therefore, a suitable coating material such as, HLB 
(hydrophilic and lipophilic balance) can be used to develop SPME extraction phase which can attain 
balanced coverage of analytes.  In addition to 𝐾 , the binding affinity of analytes to the matrix 
components 𝐾  is another important parameter to attain the balanced coverage. The correlation 
between 𝐾  and 𝐾   in balanced coverage SPME extraction can be explained comprehensively 
using computational a model (Figure 1.8). 
 
Figure 1. 8 Effects of partition coefficient (𝑲𝒆𝒔) and matrix binding constant (𝑲𝒂) on analyte 




Figure 1.8 shows the distribution of analytes in the extraction phase with variation of 𝐾  and 𝐾  
values. The recovery of analytes rises with the increase of 𝐾 , and reduces with the decrease of 
𝐾 . While the  𝐾  value of analytes contribute to the free concentration. With higher 𝐾  value 
the free concentration decreases and vice versa.  In reality, most SPME experiments involve 
extraction of analytes which are heavily bound (high 𝐾  value) to the matrix components (such as, 
diazepam, tranexamic acid and doxorubicin in blood plasma). In order to obtain a balanced 
coverage of multiple analytes HLB coating is preferable. In a tentative case, Figure 1.8 (a) 
demonstrates that analytes with lower 𝐾   and 𝐾  values will be close to equilibrium in a short 
period of time while other will be in linear extraction kinetic regime.  This indicates that, the 
extraction. While Figure 1.8 (b) shows the coverage of analytes with higher  𝐾   and 𝐾  values. 
This is because of displacement of analytes with low 𝐾  values by the ones with high 𝐾   values. 
Therefore, computational models can be used to optimize the experimental conditions where the 
balanced coverage of wider range of analytes is required.  
Overall, the use of computational models in SPME technique demonstrates as a powerful 
analytical tool for in-depth understanding and investigation of experimental process. It can be 
used to minimize the cost of analysis through optimization of experimental steps using 
computational data. In addition, it provides the explicit explanation for many complex phenomena 






1.10. An Overview of COMSOL Multiphysics  
Over the last couple of years COMSOL Multiphysics software has been used as a computational 
tool to calculate analyte mass transfer kinetics in many SPME applications. COMSOL Multiphysics 
has been frequently used in our research group over the last six years because of its intrinsic 
simplicity for non-expert users. Other computational platforms like MATLAB require in-depth 
knowledge of mathematics. This computational platform offers users a comprehensive model 
builder template for various physics interfaces such as chemical species transport, heat transfer, 
fluid dynamics, etc. An overview of this software is described in this section. Firstly, the user 
develops a preliminary model template by selecting space dimensions (such as 3D, 2D or 1D, etc.), 
physics interfaces (such as chemical species physics interface for mass transport phenomena) and 
study type (such as time dependent study or stationary study). The basic model template contains 
some classified nodes – ‘Global Definitions’, ‘Components’, ‘Study’ and ‘Results’.  
Definitions: The ‘Global Definitions’ node includes user defined variables, functions, material 
descriptions, etc., which are applicable to all components in the model. Multiple components may 
require defining multiple physics, such as ‘reaction engineering’ and ‘chemical species transport’ 
physics (Figure 1.9). ‘Definitions’ branch is available under component node as well. Definitions  
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Figure 1. 9 Snapshot of model build-up sequence in COMSOL Multiphysics 5.2 software 
The component branch also provides user defined variables, parameters and functions, boundary 
system, etc., which are restricted to the respective component (in figure 1.9 functions are not 
selected but can be obtained from model builder).  
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Geometry: Another important section of the ‘Component’ node is ‘Geometry’. It offers the 
user the option to define and develop the geometry of the component model using either 
COMSOL kernel or CAD (computer-aided design) kernel. In case of CAD kernel, the user needs to 
import the design developed in CAD module. The COMSOL kernel module includes all basic 
geometric shapes of objects (such as, blocks, cylinder, cone, sphere, etc.) and all geometric 
operations to build a component model (Figure 1.10). The user also needs to define the units 
(length and angular units). The geometric operations such as, Booleans and Partitions are 
noteworthy. These geometric operations define the partition of domains and boundaries of the 
geometric entity. For example, the ‘Difference’ Boolean operation is used to subtract one 
geometric object from another. At the end of the sequence, the user needs to perform ‘Form 
Union or, Form Assembly’. ‘Form Union’ combines all geometric entities in a single object with 
different domains and boundaries, whereas ‘Form Assembly’ treats different entities as a 
collection instead of a single entity. In latter case, the user needs to pair boundaries or domains 
to perform special mathematical operations such as – special boundary pairs are required in 
‘rotatory machine’ geometry where blades and fluid of the rotatory machine work as moving mesh 
(such as meshing of fluid) with respect to the stationary wall.  
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Figure 1. 10 A 3D geometry of SPME extraction experiment built in COMSOL kernel using different 
shapes and operational functions under ‘Geometry’ node in COMSOL Multiphysics 5.2 
 
Materials: The material section includes a library of various materials such as, polymers, alloys, 
rocks, air, different types of liquid, etc. This section is particularly important if investigation of 
material properties is required. However, the objective of this study is mainly focused on mass 
transport properties of analytes. To obtain a comprehensive mathematical model, someone might 
consider material properties as an important factor in case of mass transfer of analyte in complex 
sample matrices like biological tissue. However, COMSOL provides specific physics components 
(explained later in this section) which include the necessary properties of a specific mass transport 
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type, for example ‘transported diluted species in porous medium’. Nevertheless, ‘water-liquid’ 
material is mostly used as a medium to study the mass transfer in SPME.  
Physics: COMSOL Multiphysics provide various physics template to simulate mass transfer 
properties, such as ‘transported diluted species (tds)’ which has already been used in many SPME 
applications. to simulate mass transport of analyte in aqueous matrix when the properties are not 
of interest. tds is used to calculate concentration of a solute in air, liquid or solid (SPME). The 
driving force for mass transport in this physics is controlled by the Fick’s law of diffusion, as well 
as convection when coupled with fluid dynamics, and reaction engineering (detailed explanation 
was given in chapter 2). The dependent variable of this physics interface is molar concentration 
(c). This interface is applicable to simulate mass transport in 1D, 2D and 3D as well as axisymmetric 
components in 1D and 2D. Besides tds, some other commonly used physics interfaces in SPME are 
reaction engineering (re) and fluid flow (such as laminar flow, spf). 
Mesh: The purpose of ‘Mesh’ node in COMSOL Multiphysics is to discretize the geometry 
through meshing sequence into small units which are referred to as mesh elements.  
 
Figure 1. 11 Meshing of 2D (a) and 3D (b) geometry in COMSOL Multiphysics 5.2 using ‘trigonal’ 




Meshing sequence corresponds to meshing ‘operation’ and ‘attribute’ nodes (see Figure 1.12). 
Operation node creates or modifies the mesh of the defined geometry according to the selected 
properties. For example, ‘Free Tetrahedral’ and ‘size’ are two operation nodes. Attribute nodes 
are subnodes of operational nodes which corresponds to local operation node and overrides the 
global properties of operation nodes.  
 




In COMSOL Multiphysics, meshing operation can be performed either by ‘physics controlled’ 
or, ‘user-controlled’ meshing. Under ‘physics-controlled’ meshing operation, the software creates 
and modifies a mesh according to the default values set by the physics interfaces. In that case, the 
user needs to select the predefined element size (see Figure 1.13). However, physics-controlled 
setting may result in poor meshing resolution due to the complex shape of the geometry which 
will affect the outcome of modeling. The ‘user-controlled’ meshing operation allows the user to 
develop meshing sequence and customize respective properties of meshing nodes. User-
controlled meshing operation is the preferred choice to obtain better simulation results.  
 
Figure 1. 13 Predefined element size in COMSOL Multiphysics 5.232 
 
Studies and Solvers: COMSOL Multiphysics software follows a hierarchy approach for solving a 
problem. The ‘Study’ node is at the top level (see Figure 1.14) which contains a least amount of 
detail and a Study branch. 
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Figure 1. 14 The hierarchy sequence of ‘Study’ node in COMSOL Multiphysics 5.2 32 
 
The ‘Study’ node corresponds to a ‘study step’ which is added while creating a new model in 
the model builder. A study step defines the type of study such as, ‘Stationary’ or ‘Time-dependent’. 
Multiple study steps can be included under same branch of ‘Study’ node. A study step corresponds 
to ‘Solver Configurations’ and ‘Job Configurations’ nodes. Solver configuration includes the solver 
to solve for the dependent variables in the physics interface, and intermediate storage of 
solutions. While the job configurations node contains all jobs defined for a particular study such 
as, parametric jobs, batch jobs, etc. Although there are different types of solvers available in 
COMSOL Multiphysics, ‘linear’ and ‘nonlinear’ types of solvers were mostly used in this study. 
COMSOL automatically detects the nonlinearity of the problem and switches to a nonlinear solver.  
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Figure 1. 15 ‘Direct’ linear solver configuration is COMSOL Multiphysics 5.2 
Since this section is based purely on mathematics and COMSOL provides very limited information 
about solver configuration, only a few customized operations were performed for our study. Most 
notably, selection of ‘Direct’ linear solver (see Figure 1.15) instead of ‘Iterative’ linear solver. 
‘Direct’ contains MUMPS (multifunctional massively parallel sparse direct solver) as a default, or 
PARDISO (parallel sparse direct solver), or SPOOLES (sparse object-oriented linear equations 
solver). All these solvers use default settings.  
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Results Analysis: This section of COMSOL Multiphysics provides mathematical and analytical 
tools for post processing and analyzing results derived from simulations – examples include data 
plotting in 1D (line plots), 2D (surface plots) and 3D (volume plots). Visualization and animation of 
the results are also available.  
1.11. Research objectives  
Over the last two decades SPME technique has been extensively used for characterization 
analytical components in many complex biological matrices including blood, serum, urine, tissue, 
etc. This widespread adoption of SPME has been achieved due to its intrinsic simplicity, and ability 
to measure free analyte concentration from complex sample matrices where multiple binding 
matrices exist. The continuous evolution of SPME techniques enables it to diversify into numerous 
applications, such as in vivo applications in clinical research, direct extraction from biological 
tissues like liver, lungs, brains, etc. For example, measurement of free drug concentration in blood 
plasma and solid tissue is a critical analytical step in clinical trials. However, the concentration of 
heavily binding matrix components (such as albumins, immunoglobulins, etc.) present in the 
biological samples significantly reduces the free analyte concentration of drug, leading to 
inaccurate analytical results. Since SPME extracts negligible amounts of analyte via free 
concentration, it enables the determination of free drug concentration in complex biological 
samples. However, knowledge of the characteristics of mass transfer kinetics in the presence of 
binding matrix components is necessary in order to understand important SPME attributes, such 
as extraction equilibrium time, matrix assisted mass transfer, and local depletion. In these aspects, 
the computational model is considered as an effective analytical tool to demonstrate 
comprehensive knowledge about the mass transfer kinetics. In-silico approach can also be applied 
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to reduce experimental steps in analytical method optimization, helping to save time and cost of 
analysis. Previous efforts of computational studies for SPME extraction kinetics primarily focused 
on single binding matrix component system, containing only albumins. This simplified approach 
demonstrated how HSA binding matrix influences the mass transfer of the analyte to the 
extraction phase.17  Such computational studies onset the journey to investigate more 
complicated sample matrices like blood plasma or solid tissue, where analytes are bound with 
different components (albumins, immunoglobulins, cell membrane, etc.). This intricate binding 
nature of the matrix components complicates the efforts to investigate the mass transfer kinetics, 
because the binding matrix components also contribute to the mass transfer the of analyte. Thus, 
the apparent binding constant (which is assumed to be the true binding affinity of analyte to the 
matrix components) of the target analyte for respective matrix components needs to be estimated 
in order to investigate the mass transfer kinetics. In this regard, the study documented in this 
thesis aimed to achieve the following objectives: 
 SPME method development and optimization using computational models to 
determination the free concentration of target analyte in complex biological samples, such 
as tissue and blood plasma.  
 To demonstrate critical SPME attributes, such as matrix assisted mass transfer, local 
depletion, etc. using computational models. 
 Develop 3D computational models based on adsorption kinetics in solid coating which are 
more practical to the experimental conditions (in many SME experiments the extraction 
kinetics is followed by adsorption on solid coating). It should be noted that computational 
models using 2D axisymmetric approach can be used in many SPME experiments (usually 
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all experimental conditions applied here are compatible for 2D axisymmetric) where 3D 
models are not necessary in order to simplify mathematical calculations. However, the 3D 
models are particularly required in some experimental conditions, such as in vivo, or where 
the sample geometries are mostly asymmetric for example in a living organism. Therefore, 
the objective of using 3D models is to achieve the computational expertise for such 
applications. 
 
Chapter 2 documents the development of an SPME approach to determine free doxorubicin 
(DOX) concentration in bovine lung tissue, using solid extraction phase. 3D computational models 
were developed based on experimental data, which demonstrated the mass transfer of DOX to 
the solid extraction phase in lung tissue. Chapter 3 demonstrates the use of 3D mathematical 
models to determine free fatty acid (alpha linoleic acid and linoleic acid) concentration and 
subsequent application of the experimental data to monitor the dynamic ligand-receptor 
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The contribution of co-authors Marcos Tascon and Anna Roszkowska to the work described 
in this chapter was involved in experimental characterization from tissue. Emir Nazdrajic helped 
with mathematical equations used for mass transfer (the assistance was just discussion). All the 
assistance from co-authors were merely enough to include them in publishing the work. All major 
works – developing mathematical models, performing simulations and experimental designs 
were done by the main author. All the listed co-authors were asked for their permission to use 
this material for writing this thesis.  
2.2. Introduction 
One of the main aims of clinical pharmacology studies is to provide the most accurate 
measurements of drug concentrations in living systems, a task most likely to succeed via in vivo 
assessments of free drug concentrations at receptor sites (the biophase). Given that the majority 
of drug-receptor interactions take place in tissue, determining free drug concentrations in the 
intracellular space would be a more rational way to investigate the 
pharmacokinetics/pharmacodynamics (PK/PD) of a given drug, as compared to its measurement 
in blood plasma.39,40 These concerns are of particular importance in PK/PD studies involving drugs 
that are administered subcutaneously (SC) or intramuscularly (IM). In such cases, the in vivo free 
concentration of the administered drug in the intracellular space would be the most appropriate 
indicator of therapeutic efficiency.41 However, given the complex nature of drug distribution in 
tissue matrix as well as the limitations of traditional analytical techniques available for such 
measurements, in vitro measurement of free drug concentrations in blood plasma is oftentimes 
adopted as a surrogate technique to study PK/PD.42–44While a variety of analytical methods are 
available for measurement of free drug concentrations in tissue matrix, such as equilibrium 
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dialysis, ultrafiltration, and microdialysis,45,46 few of them are capable of in vivo measurement. 
Microdialysis (MD) is the method most widely used to monitor free analyte concentrations in the 
extracellular space of tissue. However, the MD technique encounters some limitations, such as 
low recovery for highly protein-bound nonpolar drugs, and low temporal resolution of fast 
changing tissue components. The electrochemical biosensors technique, on the other hand, is 
highly efficient for measurement of rapidly changing tissue components, since it promotes fast 
detection via chemical or biochemical reactions. However, this technique, already limited to the 
detection of electroactive analytes only, is also characterized by low specificity due to the 
presence of non-electroactive interferences.47,48 Due to technical difficulties, equilibrium dialysis 
and ultrafiltration are only used for in vitro analysis in blood plasma and other biological 
fluids.49,50 The major limitations of equilibrium dialysis encounters are longer equilibration times 
(typically 4 – 28 h), volume shifts and poor drug solubility. On the other side, the ultrafiltration 
technique prone to nonspecific interactions with matrix components and equilibrium 
displacements, producing in this way a bias stemming from overestimations of the free 
concentration value.51 Given the various shortcomings associated with MD and electrochemical 
biosensors, a simpler and more robust analytical technique is thus needed to tackle 
measurements of free drug concentrations in tissue. Solid-phase microextraction (SPME), 
developed in 1990,31 stands as particularly suitable for this application given its unique 
characteristics. In vivo SPME for analysis of tissue can be performed by placing a biocompatible 
microextraction phase coated onto a thin fiber into tissue matrix with minimal invasiveness. Here, 
unbound analytes are selectively extracted from the matrix by diffusion through the boundary 
layer. Due to negligibly depletive nature of the microextraction phase, SPME does not disturb the 
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binding equilibrium between the analyte and the matrix. Further, SPME allows for extractions to 
be carried out either in the equilibrium or pre-equilibrium regime.,17,20 These qualities of SPME 
render the technique an ideal choice for measurements of free concentration of analytes from 
complex biological matrices, as supported by its many successful applications in the biological 
field, both in vivo and ex vivo.52–54 In 2003, Lord et al. first reported the use of fiber SPME for in 
vivo monitoring of benzodiazepines in the systemic blood circulation of dogs.55 Since then, in vivo 
SPME applications have been widely exploited to study drug biomarkers and metabolomes due 
to the advantages associated with its minimally invasive direct extraction capabilities, as well as 
its ability to extract analytes with wide range of polarity, which is often referred to as balanced 
coverage [22-25].53,56–58 From a theoretical point of view, Musteata et al. explained the 
mechanism of SPME extraction of free analytes in the presence of a binding matrix under 
equilibrium conditions, where the unbound portion of the analyte partitions to the liquid 
extraction phase of the SPME fiber.[59] In addition to the use of experimental techniques, 
mathematical modelling has proven as an excellent tool to determine the kinetics of SPME 
extraction in the presence of a binding matrix, as it allows for better predictions of results while 
minimizing the number of experiments that must be carried out during method development 
and routine analysis [17, 27, 28].17,18,60 Alam et al. first successfully the effects of a binding matrix 
on the extraction kinetics of SPME liquid coatings via development of a 2D model in COMSOL 
Multiphysics.17 Gorecki et al. and Zhou et al., in turn, demonstrated the extraction kinetics of 
solid coatings with the use of Langmuir’s isotherms, which approach assumes isotropy of the 
fiber surface.61,62 Since most of the biocompatible microextraction phases currently employed in 
SPME experiments for biological applications consist of a solid coating, the current work has 
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focused on developing mathematical simulations of SPME kinetics in tissue matrix for solid 
coatings. To the best of our knowledge, this is the first time a mathematical model to measure 
free drug concentrations from tissue matrix via SPME is reported in the literature. Of note, the 
developed model, which allows for calculations of binding constants and free concentrations of 
relevant drugs directly from tissue, opens an exciting new area of study in bioanalytical chemistry.  
2.2.1. Doxorubicin case study 
Doxorubicin (DOX) is a widely known chemotherapeutic agent that has been used for over 
40 years in the treatment of many different types of cancers. The mode of action involves the 
binding of DOX which causes potential cytotoxic effects and limits the proliferation of malignant 
tissue by intercalating with DNA base pairs. However, this drug is nonselective in nature, for 
which it inherits adverse side-effects by damaging healthy tissue. To reduce such side-effect, in 
most cases, DOX is administered locally to the site of action. Since the site of action of DOX is 
intracellular and it enters into the cell through passive diffusion like most other small molecules, 
the drug has been commonly administered intravenously (IV).63,64 Pharmacokinetic studies have 
shown that DOX has a plasma half-life of 3-5 min, and a tissue half-life of 24-36 h. This indicates 
rapid uptake of DOX by tissue matrix. However, passive diffusion of DOX depends on the free 
form of DOX in the extracellular matrix, where it is heavily bound to multiple extracellular species. 
To the best of our knowledge, no studies have been reported estimating the free concentration 
of DOX in tissue matrix.65 More recently, DOX has been under preclinical study for treatment of 
metastatic lung cancer through in vivo lung perfusion (IVLP), where DOX concentration in lung 
tissue was determined by measurement of total drug concentrations in perfusate solution and 
serum.66 In these scenarios, it is of great bioanalytical interest to develop a novel technique 
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capable of determining the free concentration of a drug in biological tissue by direct sampling, 
with minimum invasiveness so as to also enable in vivo applications. The current work presents 
the SPME extraction kinetics for solid coatings in tissue using numerical and experimental 
models. As a proof of concept, DOX was selected as a model drug, while bovine lung tissue was 
selected as the biological matrix. The physics of the biological matrix was also modeled based on 
fundamental and biological parameters, such as tortuosity and intracellular space of the tissue 
matrix, since these factors control drug diffusion and distribution. Experimental results were then 
attained and compared with the developed numerical simulations. Once optimized, the model 
enabled calculations of free drug concentrations as well as relevant concepts for in vivo sampling, 
such as sampled area, depleted area, and spatial resolution.  
2.2.2. Theoretical considerations 
SPME extraction takes place via free concentration. If the amount extracted is negligible, 
then the equilibrium concentration of the analyte in the sample matrix is equivalent to the free 
concentration, which is measured according to eq. 1.5: 
𝑛 = 𝐾 𝑉 [𝐴]                                                                                    
Where: 𝑛 is the amount of analyte extracted on the fiber coating at equilibrium, 𝐾  is the partition 
coefficient and 𝑉  is volume of the extraction phase. Since 𝐾  and 𝑉  are constants for particular 
analyte and specific extraction phase, then the above equation can be formulated as below: 
𝑛 = 𝑓 ∗ [𝐴]                                                                             (2.1) 
Where, 𝑓 = 𝐾 ∗ 𝑉  is the fiber constant. The partition coefficient 𝐾  is derived from the 





                                                                          (2.2) 
However, when solid coatings are employed in SPME, analytes are adsorbed on the active surface 
area rather than partitioned, making the above eq. (2.2) inadequate for measurements of free 
concentrations under these conditions. A theoretical approach based on Langmuir’s theory for the 
extraction kinetics of solid coating SPME has been previously proposed in the literature [18,67]. In 




                                                                          (2.3) 
Where γ  is the maximum free active-site concentration in the fiber (mol m-2), 𝐾 is the adsorption 
equilibrium constant (m3 mol-1), and [A]eq is the free concentration of analyte in the matrix at 
equilibrium (mol m-3).  
The mass transfer in solid coatings is defined by Langmuir’s isotherm, which is defined as: 
𝑟 − 𝑟 =  𝑘 ∗ [𝐴] ∗ (1 − 𝜃) − 𝑘 ∗ 𝜃                         (2.4) 
Where, 𝑟  is the rate of adsorption of analyte onto the coating surface (mol m-2 s-1); 𝑟  is the 
rate of desorption (mol m-2 s-1); 𝑘  is the adsorption rate constant (m s-1), and 𝑘  is the 
desorption rate constant (mol m-2 s-1). For solid coatings, the rates of adsorption and desorption 
are dependent on the fraction of vacant sites available on the solid surface, which is defined as θ. 





Where 𝑐𝑠 is the amount extracted on the fiber at a given time t, and γ  (mol m-2) is the maximum 
active surface concentration. The latter can be defined as follows: 
γ =
     
    
=    (2.5) 
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Eq. (2.4) can be rearranged as: 




                     (2.6) 




[ ] ∗( / )
                                                        (2.7) 
Eq. (2.6) provides the partition coefficient value for an analyte in a given solid coating. However, 
if the extracted amount is significantly high, significant depletion of the free concentration of the 
analyte in the local area of the fiber will occur after the system reaches equilibrium. If we consider 
the extraction of analyte without any binding matrix present in the system, the free concentration 
will be same as the total concentration. Therefore, eq. (2.1) can be expressed as follows: 
[𝐴] = [𝐴] + ; where    is the depletion of concentration    (2.8) 
And eq. (2.6) and eq. (2.7) can be rewritten as: 
[𝐴] = [𝐴] + =  
/
∗( / )
+                                   (2.9) 
[𝐴] =  
∗( )
+                                                           (2.10) 
Eq. (2.10) provides the free concentration of analyte extracted by a solid coating without the 
presence of a binding matrix.  
2.2.3. Mass transfer kinetics in presence of binding matrix 
 
In the presence of a binding matrix with univalent binding sites of uniform affinity, analyte A 
is in equilibrium with the matrix component M, where the binding association constant 𝐾  is given 
by the eq. (2.11) 
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A + M <=> AM 
𝐾 =  =  
[ ]
[ ] ∗[ ]
                                                                  (2.11) 
Where: 𝑘 , 𝑘 , and [𝐴]  are the rate of association, rate of dissociation, and concentration of 𝐴 
at equilibrium, respectively. [𝑀] is the concentration of the binding matrix, and [𝐴𝑀] is the 
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[ ] ∗([ ] [ ] [ ] )
                                  (2.12) 
Where, [𝐴]  is the total concentration of analyte or initial concentration, [𝐴]  is the free 
concentration of analyte, and [𝑀]  is the total matrix concentration. 
If the binding matrix concentration [M] ≫ [A]tot, then eq. (2.12) can be rearranged as: 
𝐾 ∗ [𝑀] =
[ ]
[ ]
− 1                                                          (2.13) 
A linear regression line can be obtained from eq. (2.14), where the slope gives the value of the 
binding association constant 𝐾 . Eq. (2.8) determines the amount of free analyte extracted by the 
extraction phase in absence of any binding matrix. However, in the presence of a binding matrix 
the amount extracted into the extraction phase can be derived from eq. (2.8) and eq. (2.13): 








=  (𝐾 ∗ [𝑀] + 1) ∗
[ ]
                                            (2.14) 
The binding association constant can thus be calculated by using eq. (2.13). Interestingly, the 
product of 𝐾 . [𝑀]  from eq. (2.14) is a unitless constant, which we can consider as the apparent 
binding constant 𝐾 = 𝐾 . [𝑀] . In this chapter, eq. (2.14) was used for the binding study of 
DOX with tissue binding matrix. For mathematical simplification, we assumed that DOX binds 
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univalently to a single site of HSA in this case study. However, we justified the mathematical 
limitations by fitting the experimental results with simulations. For experimental results we 
extended the equilibrium conditions described above by the exact equations to transient 
situations prior to equilibrium using numerical modeling. 
2.3. Experimental 
2.3.1. Materials and supplies  
 
Human Serum Albumin (HSA), doxorubicin hydrochloride (DOX), formic acid (FA), and 
ammonium acetate (LC-MS grade) were purchased from Sigma–Aldrich (Oakville, ON, Canada). 
Agar gel, methanol (MeOH), and water were LC-MS grade and purchased from Fisher Scientific 
(Mississauga, ON, Canada). C-8 mixed mode SPME fibers were kindly provided by Millipore-Sigma 
(Oakville, ON, Canada). A phosphate-buffered saline solution (PBS) at pH 7.4 was prepared 
followed by standard procedure available in many literatures. Standard stock solutions were 
prepared in methanol at a concentration of 2000 µg∙mL-1 and stored at -80 ºC. Bovine lung tissue 
was purchased from a local meat shop, and the respective experiments were conducted with the 
approval of the University of Waterloo’s Office of Research Ethical Board.  
2.3.2. Measurement of maximum surface concentration of DOX (𝛄𝐬) 
 
According to eq. (2.5), the maximum site concentration of doxorubicin on the fiber coating 
is attained once equilibrium is reached. To determine the value of γ  of DOX on a C-8 mixed mode 
SPME fiber, equilibrium extractions were performed at 0.5, 1, 2, 3, 4, and 5 µg∙mL-1 initial 
concentrations in PBS under agitation at 1500 rpm. The amount of DOX extracted at equilibrium 
was determined using LC-MS method. The active surface area of the fiber coating was determined 
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via Brunauer–Emmett–Teller (BET) analysis.  
BET is the most widely used method for measurement of surface area of porous materials (solids). 
In BET analysis, an inert gas typically pure nitrogen is purged onto solid material surface under 
isothermal condition, while the pressure of the gas is increased. Therefore, the gas molecules will 
be adsorbed onto the solid surface and occupy the pores of the material. With respect to the 
Langmuir’s isotherm which is limited to the monolayer, BET theory extends to the multilayers. 
Since the cross-section of the gas molecule is known, the specific surface area and pore volume 
can be calculated using BTE equation as follows: 
[ ]
= + ( )     (2.15) 
Where X is the weight of gas molecule (typically N2) adsorbed at a given relative pressure   .  
is the monolayer capacity according to the Langmuir’s isotherm, and 𝐶 is a constant. Eq. (2.15) is 
a linear equation. The isotherm obtained for SPME coating materials in BET analysis is given below: 
 
Figure 2. 1  BET isotherm of C-8 mixed mode SPME fiber. 
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The surface area from BET isotherm is calculated by the following equation: 
 
𝑆𝑢𝑟𝑓𝑎𝑐𝑒 𝐴𝑟𝑒𝑎 (𝑆𝐴) = ∗ 𝐶𝑆𝐴 (𝐶𝑟𝑜𝑠𝑠𝑒𝑐𝑡𝑖𝑜𝑛𝑎𝑙 𝑎𝑟𝑒𝑎 𝑜𝑓 𝑁 ) (2.16) 
 
The surface area of porous material provides the information about pore size distribution.  
 
Figure 2. 2  Physical characterization of active surface area of commercial mixed mode C-8 SPME 
fiber using BET (Brunauer, Emmett and Teller) method 
 
In Fig. 2.1, X axis describes the different sizes of pores distributed onto the C-8 mixed mode 
material. We assumed that the interaction of DOX with extraction phase takes place on the outer 
surface of the material and the porous surface. To calculate the approximate specific surface area 
of the extraction phase, we ignored the pores smaller than 80Å considering the fact that it is 
difficult for DOX molecule to accesses such small pores. Based on this assumption, the active 
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surface area was measured as 1.98 m2/g. The value of maximum surface concentration (γ ) can 
be obtained from eq. (2.5). 
 
Figure 2. 3  Amount of extract (in ng) with variation in initial concentration of DOX (ppm) from PBS 
solution spiked with standard DOX 
Table 2. 1  Experimentally measured physical parameters of SPME extraction phase 
Parameters Measured 
Specific surface area of SPME fiber coating (m-2/g) 1.98 
Amount of particles per fiber (g) 2.30E-05 
Specific surface area per fiber (m2) 4.55E-05 
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2.3.3. Measurement of the adsorption equilibrium constant (𝑲)  
 
For DOX The adsorption equilibrium constant (K) for doxorubicin onto a C8 mixed mode 
SPME extraction phase was attained by carrying out extractions under the following conditions: 
agitated equilibrium extractions from PBS were carried out using two different initial 
concentrations (Table 2.2). Doxorubicin was spiked at 100 ng∙mL-1 and 50 ng∙mL-1 in PBS at pH 7.4. 
Extractions were performed at 1500 rpm with preconditioned SPME C-8 mixed mode fibers. Fibers 
were preconditioned with ACN/H2O (80/20) for 30 mins. An extraction time profile was obtained 
at eight different time points by independent triplicates, within a 120 min period. After each 
extraction time step, fibers were gently cleaned with Kim wipes and rinsed with 300 μL of LC-MS 
grade water for 10 s to remove salts and unspecific attachments from the coating. Desorption was 
performed with 300 μL of ACN/H2O (80/20 + 0.1% FA) for 60 min in a shaker at 1500 rpm. The 
estimated value of 𝐾 was determined using eq. (2.9). 
Table 2. 2  Experimentally calculated adsorption equilibrium constant 𝑲 
[A]init (mol m-3) cseq (ng) [A]eq (mol m-3) cseq (mol m-2) K (m3 mol-1) 
K (m3 mol-1) 
Average 
9.20E-05 49.2 3.87E-05 1.99E-06 466.7 
≈ 468 
1.84E-04 97.98 7.79E-05 3.96E-06 469.9 
 
2.3.4. Development of 3D mathematical models in COMSOL Multiphysics 
 
3D models of different extraction conditions using C8 mixed mode SPME fiber immersed 
directly into the sample matrix were designed in to COMSOL Multiphysics 5.3 (Figure 2.4). The 
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shape of the sample matrix was considered rectangular with respect to the equivalent volume of 
cylindrical glass vial, in order to simplify the mathematical calculation. The volume of the sample 
matrix was 17 mL. The 3D geometry is shown in Figure 2.4. The shape of the sample matrix was 
designed s a rectangular shape instead of vial for simplicity, however the total volume remains 
same. The whole system was divided into two domains – the sample matrix and the solid extraction 
phase. The solid support (the fiber) was excluded from the simulation since it doesn’t take part in 
the mass transfer of analyte. The extraction kinetics takes place at the boundary between the 
extraction phase and sample matrix, which is defined as the mass flux according to the Fick’s law 
of diffusion. The mass transfer in both domains (sample matrix and extraction phase) was defined 
by the ‘transported diluted species (tds)’ physics interface in COMSOL Multiphysics. This physics 
interface simulates the transport of diluted chemical species in a solvent driven by the diffusion 
and convection (when coupled with fluid flow). The transport media could be a liquid solvent, a 
gel, or a porous solid immersed in a liquid solvent.  ‘Laminar flow (spf)’ physics was used in COMSOL 
Multiphysics to simulate the convection in the sample domain. This ‘laminar flow (spf)’ physics 
couples the functionalities of ‘transported diluted species (tds)’ of sample domain with the single 
phase fluid flow (convection). The fluid flow of the sample domain was defined as a single phase 
because of the Reynolds number (𝑅𝑒) calculated for the experimental conditions ( vortex speed of 
the sample during the extraction) was way below the threshold value (𝑅𝑒 <
2000; 𝑙𝑎𝑚𝑖𝑛𝑎𝑟 𝑓𝑙𝑜𝑤). The Reynolds number can be obtained by the following equation: 




𝑅  = Reynolds number; 𝜌 = density of the fluid; U  = linear flow velocity 
𝐿 = characteristic linear length scale; 𝜇 = dynamic viscosity of the fluid 
We can convert the vortex speed into linear velocity of the fluid using following equation: 
𝑣 = 𝜔𝑟 
Where 𝑣 is the linear velocity (m s-1); 𝜔 is the angular speed (𝜔 = 2𝜋 × 𝑟𝑜𝑡𝑎𝑡𝑖𝑜𝑛 𝑝𝑒𝑟 𝑚𝑖𝑛𝑢𝑡𝑒), 
which is the vortex speed in this case; and 𝑟 is the radius of the sample vial. The linear velocity of 
fluid is calculated app. 0.5 (m s-1) for 1500 rpm in a vial with 0.5 cm radius. Using this linear velocity 
in computational model, the cell Reynolds number was obtained <40 which satisfy the selection of 
‘laminar flow (spf)’ physics interface. 
 
Figure 2. 4 (a) 3D geometry of an SPME fiber in rectangular box. The volume (W: D: H = 10mm x 
10mm x 17mm) of the box is equivalent to the experimental sample volume. (b) A close view of 
SPME fiber coating. The thickness of the fiber is 45 µm 
 
The physical parameters used for extraction simulation in bovine lung tissue are given Table 2.3. 
The details of the extraction kinetics are discussed in Results and Discussion section. 
 
47  
Table 2. 3  Parameters used for all computational modeling in COMSOL Multiphysics 
Paremeter name Expression unit Description 
A_init 4.60E-05 mol/L Initial concentration of DOX 
B_init 2.00E-01 mol/L 
Adjusted binding matrix concentration 
in tissue 
Ds_A 6.54E-06 cm^-2/s 
Diffusion coefficient of DOX in tissue 
matrix 
Ds_B 6.54E-07 cm^-2/s 
Adjusted diffusion coefficient of binding 
matrices in tissue matrix 
T_in 298 K 
Ambient temperature of experimental 
condition 
vD 10 mm 
Diameter of the sample matrix 
dimension 
vH 17 mm Height of the sample matrix dimension 
vW 10 mm Width of the sample matrix dimension 
Mw 543.5 g/mol Molecular weight of DOX 
Mb 6.65E+04 g/mol Molecular weight of has 
b 145 μm SPME fiber outer coating diameter 
a 100 μm SPME fiber diameter 
l 15 μm Coating length 
Ka 6.20E+03 L/mol Binding constant of DOX with HSA 
kr 0.5 1/s 
Rate of association of DOX with HSA 
matrix 
kf Ka*kr L/(mol*s) 
Rate of dissociation of DOX from HSA 
matrix 
K 468 L/mol Adsorption equilibrium constant 
k_ads 6.50E-05 m/s 
Adsorption rate constant of DOX on 
extraction surface 
k_des k_ads/K mol/(m^2*s) 
Desorption rate constant of DOX from 
extraction surface 
ϒ_s 1.12E-05 mol/m^2 Maximum active site concentration 
Af 4.55E-04 m^2 Active surface area per fiber 
 
The numerical values used for simulation were obtained from experimental conditions, such as 
the SPME extraction phase dimensions – length of the extraction phase is 15 mm. Table 2.3 
contains all the parameters used for three four different computational models (static extraction 
in agar gel, agitated extraction in PBS solution, agitated extraction in PBS with HSA, and static 
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extraction in tissue). Some parameters were inactive in respective computational model where it 
was not required, for example, linear velocity is not required in static extraction. It should be 
noted that the diffusion coefficient for binding matrix components in tissue is adjusted in 
comparison with the diffusion coefficient for HSA.68 
 
2.3.5. Static extraction time profile of doxorubicin in agar gel 
 
In this experiment, we evaluated the kinetic profile for static extraction of DOX in the 
absence of a binding matrix. Agar powder (0.8%, w/w) was added in PBS (1X, pH 7.4) spiked with 
100 ng mL-1 of DOX. The mixture was heated at 70⁰C in a water bath for 30 min. Once the agar 
powder was completely dissolved, the solution was transferred to 2 mL glass vials and allowed to 
cool at room temperature until it attained a gel consistency. Then, a preconditioned SPME fiber 
was inserted into the vial containing 1.8 mL of agar gel. Static extraction was performed with five 
replicates and at eight different time points over 120 hrs. After each extraction time points, fibers 
were cleaned with Kimwipes and vortexed with 300 μL of LC-MS grade water for 10 s to remove 
matrix components from the coating. Desorption was performed with 300 μL of ACN/H2O (80/20 
+ 0.1% FA) for 60 min in a shaker at 1500 rpm.  
Mathematical model: The 3D geometry was separated into two domains –the  sample matrix and 
the extraction phase (see the Figure 2.4). The objective was to calculate the mass transfer of a 
chemical species (DOX in this case) which is transported from one domain to another.  
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Figure 2. 5  Two domains of 3D geometry of SPME extraction (static) in agar gel defined with 
‘transported diluted species (tds)’ physics interface 
 
That mass transport is driven by diffusion which can be defined by Fick’s law. To determine the 
mass transport between the interface of the two domains, the ‘transported diluted species (tds)’ 
physics interface from COMSOL Multiphysics was selected for both domains. Under static 
extraction condition and without the presence of any binding matrix (agar is considered as a matrix 
lacking any binding affinity to the analyte), diffusion is the only governing force for mass transport. 
Therefore, the time-dependent mass balance equation for the bulk can be described according to 
eq. (1.6). 
 − ∇ ∗ (𝐷 ∇𝑐 ) = 0    (2.18) 
Where, 𝑐  (mol m-3) is the concentration of DOX in agar gel, and 𝐷  (m2s-1) is the diffusivity in the 
bulk. It should be noted that the extraction phase is considered as a porous solid where the analyte 
partakes in surface reactions (adsorption and desorption). Therefore, the mass balance equation 
for the solid surface can be described by the following equation: 
50  
− ∇ ∗ (𝐷 ∇𝑐 ) = 𝑅     (2.19) 
Where, 𝑐  (mol m-2) is the analyte concentration in the extraction phase (solid surface), 𝐷  is the 
diffusivity  in the extraction phase, and 𝑅 is the resultant of surface reactions. R can be defined as: 
𝑅 = 𝑟 − 𝑟  
According to eq. (2.6); 







Where, Now, eq. (2.19) can be expressed as:  




    (2.20) 
The variable 𝑐  in eq. (2.18) and 𝑐 in eq. (2.20) are both time and space dependent. Therefore, 
both the initial conditions and the boundary conditions are required to solve these equations. 
The initial conditions for numerical models are given below:  
𝑐 =  𝐴   [bulk] 
𝑐 =  0  [surface] 
Boundary conditions: The boundary conditions for domain 1 (Figure 2.5) were set at the outer 
boundary and the interface of the two domains. The mass flux of the analyte across the outer 
boundary is zero. Which implies no analyte can cross the outer boundary. Therefore- 
−∇ ∗ (𝐷∇𝑐 ) = 0   [at the outer surface of the sample] 
However, there is a mass flux at the interface of two domains due to surface reactions.  
−∇ ∗ (𝐷∇𝑐 ) = −𝑟 + 𝑟   [sample-extraction phase interface] 
Or, 




      (2.21)  
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The negative sign of −𝑟  indicates that the concentration of the analyte in the bulk decreases 
due to adsorption onto the solid surface, whereas 𝑟  increases. 
This boundary conditions for the domain 2 were set at the interface of two domains and the inner 
surface of the extraction phase which is connected to a metallic fiber (the extraction phase is 
coated onto a metallic fiber which does not contribute to the mass transfer). Therefore, the 
boundary condition at the inner surface is - 
−∇ ∗ (𝐷∇𝑐 ) = 0 
And the boundary condition at the interface of two domains- 
−∇ ∗ (𝐷∇𝑐 ) = 𝑟 − 𝑟  





 The same boundary conditions for mass transfer of DOX were maintained for the rest of the 
mathematical models. Detailed mass transfer kinetics of DOX in r solid coating has been explained 
in the ‘results ad discussion’ section.  
Meshing: User controlled meshing was performed using ‘Free Tetrahedral’ meshing elements. The 
geometry of SPME extraction is divided into two domains – Sample matrix (Domain-1) and the 
Extraction phase (Doman-2). Domain-1 was meshed with predefined size – ‘Extra Fine’, and 
Domanin-2 was meshed with predefined ‘Extremely Fine’ size. Since SPME extraction phase is very 
small compared to the sample matrix, the smallest possible meshing unit was used for the 
extraction phase to increase the meshing resolution.  
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Figure 2. 6   The meshing of SPME geometry in COMSOL –(a) side view of extraction phase domain; 
(b) top view of extraction phase domain; (c) the whole geometry 
 
Study: In this section ‘Time dependent’ study was selected to calculate the time-dependent mass 
transport at the interface of two domains. Solvers were selected for time dependent study as  
‘Direct’ and ‘Fully coupled’. The ‘Direct’ solver corresponds to a linear solver -MUMPS and the 
‘Fully coupled solver’ included both linear solver and nonlinear solver (constant Newton). 
 
Figure 2. 7  The solver sequence for Time-dependent’ study of static extraction of DOX in agar gel 
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2.3.6. Agitated extraction time profile of doxorubicin in PBS  
DOX was spiked in PBS (1X, pH 7.4) at the concentration of 100 ng mL-1. Extraction was 
performed with preconditioned SPME C-8 mixed mode fibers with five replicates and at 1500 rpm 
vortex speed. The extraction time profile was obtained at eight different time points over 120 min. 
After each extraction, washing and desorption were performed followed by aforementioned 
method.  
Mathematical model:  The physics interfaces for sample matrix and the extraction phase were the 
same as for the static extraction condition. To simulate the convection in the sample domain, 
‘laminar flow (spf)’ physics was selected. The fluid flow kinetics in the real experimental conditions 
is a vortex flow in finite volume. However, it is very difficult to develop such computational model 
due to the high number of degrees of freedom (number of mesh elements). To simplify the 
mathematical model, a single phase ‘laminar flow (spf)’ physics interface was chosen to simulate 
the fluid dynamics. The ‘laminar flow (spf)’ physics was coupled with sample domain physics 
‘transported diluted species 1 (tds1)’ in order to provide the convection force for the transport of 
the diluted species (DOX) in the sample domain. Therefore, the mass transfer of DOX in the sample 
domain is controlled by convective-diffusion which can be defined by Fick’s equation followed by 
eq. (1.7) and eq. (2.19). 
Mass transfer in the sample matrix:  − ∇ ∗ (𝐷 ∇𝑐 ) + 𝒖 ∗ ∇𝑐 = 0 [convective-diffusive] 
Mass transfer in the extraction phase:  − ∇ ∗ (𝐷 ∇𝑐 ) = 𝑅   [diffusive] 
The initial conditions for analytes concentration in the sample matrix and the extraction phase are 
the  same as for static extraction in agar gel. The boundary condition at the sample-extraction 
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phase interface was the same as for static extraction (eq. 2.19). 
The ‘laminar flow (spf)’ physics interface is based on the Navier-Stokes equations for conservation 
of mass, momentum, and energy. 
 
+ ∇ (ρ𝒖) = 0       (2.22) 
𝜌
𝒖
+ ρ (𝒖. ∇)𝒖 = ∇. [𝑝𝐈 + 𝐊] + 𝐅     (2.23) 
𝐅 =  μ (∇𝒖 + (∇𝒖)  )      (2.24) 
Where, ρ is the density (kg m-3), 𝒖 is the velocity vector (m s-1), 𝑝 is the pressure unit (Pa), 𝐊 is the 
viscous stress tensor (Pa), 𝐅 is the volume force vector (N m-3), μ is the dynamic viscosity (Pa s) 
and 𝑇is the temperature (K). Eq. (2.22) is a continuity equation which characterizes the 
conservation of mass. Eq. (2.23) is a vector equation which characterizes the conservation of 
momentum.  
 
Figure 2. 8  3D geometry of SPME extraction with boundary set up  
The boundary conditions for laminar fluid flow are shown in Figure 2.8. The solid wall boundary 
was ‘No slip’. It is set for all boundaries except overridden by other conditions set particularly to 
any other boundaries. 
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Wall = No slip; where 𝒖 = 0.  
Inlet: 𝒖 = −𝒏𝑈    Outlet: 𝑝 = 0  Initial condition: 𝑈 = u_init 
Where 𝒏 is the boundary normal pointing out of the domain, 𝑈  is the linear flow velocity. The 
outlet condition can be set either pressure of velocity to specify the stress. A ‘static’ pressure 
option is select from the model to set the tangential stress component at zero. Also ‘Suppress 
backflow’ check is selected to reduce the amount of fluid entering the domain through the 
boundary. The other boundary walls of the sample domain were designated as symmetric walls to 
reduce their size for solving problem. The initial condition of the fluid flow is set by the linear 
velocity parameter. 
Mesh: The meshing sequence is selected as ‘User-controlled mesh’. The meshing sequence is 
given below: 
 
Figure 2. 9  Meshing sequence of 3D SPME geometry in COMSOL for agitated extraction condition 
Study: This node included both ‘Stationary’ for ‘laminar flow (spf)’ physics and ‘Time dependent’ 
for remaining physics. Both ‘Stationary’ and ‘Time dependent’ steps were subnode of ‘Study’. The 




Figure 2. 10  ‘Study’ sequence for SPME extraction kinetics in PBS under agitation 
 
2.3.7. SPME extraction of DOX in presence of HSA binding matrix  
  Human Serum Albumin (HSA, 3.6%, w/w) was added in PBS at pH 7.4. Then 100 ng∙mL-1 of 
DOX was spiked into that mixture. In order to ensure the binding reaction reached equilibrium, 
the solution was incubated overnight at room temperature at 250 rpm. An extraction time profile 
was performed using preconditioned C-8 mixed mode SPME fibers for 10 different time points 
over 120 mins.  
Mathematical model: The physics interfaces selected for this model were – ‘reaction engineering 
(re)’ to define the binding kinetics between the analyte (DOX) and the binding matrix HSA, 
‘transported diluted species (tds)’ for the sample domain, ‘transported diluted species 2 (tds2)’ 
and laminar flow (spf)’. The ‘reaction engineering (re)’ physics is selected in a separate component 
while building the model in the wizard, because this physics interface is 0D in COMSOL by default, 
and the space dependent model can be generated according to the parameters defined by the .  
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Figure 2. 11 The ‘reaction engineering (re)’ physics interface in COMSOL Multiphysics 5.2 
 
The reaction for this study is defined as a reversible reaction between the analyte (DOX, A) and 
the binding matrix (HSA, B): 
𝐴 + 𝐵 <=> 𝐴𝐵 
The reaction kinetics depends on temperature (𝑇) and volume (𝑉). The volume for this reaction 
was constant, therefore the time-dependent mass balance equation can be defined as: 
= 𝑅∗       
Where,  denotes the change of concentration of species (𝑖) with respect to time (𝑡), 𝑅∗ is the 
rate expression of species (𝑖). The rate of expression can be defined as: 
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𝑅∗ = 𝑣 𝑟  
Where, 𝑣  is the activity coefficient of 𝑗 number of species (𝑖), and 𝑟  is the reaction rate which 
can be expressed as:  
𝑟 = 𝑘 ∏ 𝑐 − 𝑘 ∏ 𝑐 ∈  ∈    (2.25) 
Where, 𝑘  and 𝑘  denote the forward and backward reaction rate. The equilibrium constant for 
this reaction can be defined as binding association constant 𝐾  which is the ration of forward and 
backward reaction rates at equilibrium.  
𝐾 =        (2.26) 
The binding association constant, 𝐾  is determined experimentally from the slope of the binding 
isotherm (discussed in the Results section). For the mathematical modeling, the rate of 
dissociation of the analyte (DOX) from the binding matrix (HSA) is very fast and in the range of 0.1 
to 1 [s-1]. The assumption is true for many analytes.17 In this case, it was considered 0.5 [s-1] (since 
we have already determined the binding association constant𝐾 , the backward reaction rate only 
affects the time to reach equilibrium, and in our case is considered negligible unless the 
dissociation rate is extremely slow which may impact matrix assisted mass transfer).   The initial 
conditions for this reaction are: 
𝐴 =  𝐴_  𝐵 = 𝐵_   and 𝐴𝐵 = 0 
Where, 𝐴_  is the initial concentration of the analyte, 𝐵_  is the initial concentration of binding 
matrix, and 𝐴𝐵 is the initial concentration of the matrix-bound analyte at the beginning of the 
reaction. Since, this reaction kinetics affect the mass transport properties in the sample domain 
(we ignored the binding reaction in the extraction phase, since extraction phase material is 
59  
restricted to macromolecules like proteins),34,35 a space-dependent-model was generated coupled 
with ‘transported diluted species 1 (tds)’ and ‘laminar flow (spf)’ physics. 
 
Figure 2. 12  Space-Dependent Model for ‘reaction engineering (re)’ physics interface 
The space-dependent model creates a new physics ‘Chemistry (chem)’ in component-2. 
‘Chemistry (chem)’ under component-2 (3D) is now the space and time dependent physics for 
reaction engineering which contains all the variables and parameters of ‘reaction engineering (re)’ 
physics under defined properties. The ‘reaction engineering (re)’ physics also transfers the kinetic 
properties of the reaction to the sample domain since it affects the mass transfer (see Figure 2.13). 
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Figure 2. 13 The physics interface of the sample domain (1) contains the reaction kinetic properties 
 
The time dependent mass balance equations and initial conditions for the physics interfaces – 
‘transported diluted species 1 (tds)’ for mass transfer in the sample domain, ‘transported diluted 
species 2 (tds2)’ for mass transfer in the extraction phase, and the ‘laminar flow (spf)’ for fluid flow 
in the sample domain are the same as for the previous model explained for SPME extraction 
kinetics in PBS under agitation.  
Mesh: The meshing was generated by ‘User-controlled’ configuration and the properties were the 
same as for the previous model – ‘SPME extraction kinetics in PBS under agitation’.  
Study: Two separate ‘Study’ nodes were developed – one for the ‘reaction engineering (re)’ 
physics in component-1 node, another for the remaining physics in component-2 (see Figure 2.14).  
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Figure 2. 14  Study design for SPME extraction kinetics of DOX in presence of HSA binding matrix 
One of the important factors in the ‘Study’ node is to set the initial values and variables solved for 
‘Study 2’ section as user controlled, and then solving of time dependent study-1 (according to 
Figure 2.13). This will allow the time dependent study-2 to take the initial values of the species in 




2.3.8. Experimental measurement of binding constant 𝑲𝑨 of DOX with HSA 
The binding constant 𝑲𝑨 for DOX was determined according to eq. (2.13). 




Where, [𝑀] , [𝐴]  are the initial concentrations of binding matrix (HSA) and DOX respectively. 
The superfix 𝑡𝑜𝑡 was used instead of init, to define the total matrix concentration in a sample 
matrix where multiple binding matrix components are present (such as tissue). [𝐴]  is the free 
concentration of DOX experimentally determined by SPME extraction. In experimental study, five 
mixtures of DOX-HSA were prepared in PBS solution each of which was spiked with 100 ppb DOX 
and different concentration of HSA matrix (see Table 2.4 in Result and Discussion). 
2.3.9. Extraction of DOX from homogenized lung tissue  
Bovine lung was cut into small pieces and homogenized using dry ice and a meat blender. 
Doxorubicin was spiked into homogenized lung tissue (10g of each sample) at concentration levels 
5, 10, 15, 25, and 50 µg∙mL-1. After spiking, samples were gently vortexed at 500 rpm for 2 hours 
and then stored at 4⁰C overnight for binding. The following day, each sample was equilibrated at 
room temperature for an hour. Extractions were performed from 1g of tissue sample for 25 mins 
under equilibrium conditions. After extractions, fibers were properly cleaned (wiped with 
Kimwipes) and rinsed with 300 μL of Milli Q water for 10 sec to remove attached tissue matrix and 
other unspecific matrix components, then submitted to desorption in a vial with 300 μL of 




Mathematical modeling: A 3D mathematical model was developed (see Figure 2.15) using 
following physics interfaces – ‘reaction engineering (re)’ in Component-1 to demonstrate the 
reaction kinetics of DOX with the binding matrix components in the tissue, ‘transported diluted 
species (tds)’ and ‘transported diluted species 2 (tds2) in Component-2 to define the mass 
transport in the tissue and the extraction phase, respectively. No convection was involved in mass 
transfer. The space-dependent reaction engineering physics - ‘Chemistry (chem)’ was generated 
in Component-2.  
 
Figure 2. 15  The ‘Model Builder’ section of COMSOL Multiphysics 5.2 showing all the components, 
studies and physics included for simulation of SPME extraction of DOX from tissue 
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The binding reaction for DOX in the tissue matrix has been simplified in this model. There are 
different types of binding matrices present in the tissue and the initial (or total) concentration of 
each type of binding matrix is unknown (it is also practically very difficult to determine, if not 
impossible). To simplify this problem, all different types of binding matrices are considered as one 
and the binding affinity of DOX for each different matrix was considered as the apparent bind 
constant 𝑲𝑨𝒑𝒑. However, this oversimplification did not affect the determination of the value of 
𝑲𝑨𝒑𝒑 which has been rationalized in the ‘results and discussion’ section.  
Mass transfer: The mass transfer in the tissue matrix is controlled by the diffusion and matrix 
assisted mass transfer (the binding matrices contributes to the mass transfer). The time-
dependent mass balance equation in tissue can be defined as: 
− ∇ ∗ (𝐷 ∇𝑐 ) = 𝑅       
Where, 𝑅 denotes the source term which defines if the analyte is consumed or produced in the 
system. Since the binding components near to the extraction phase surface release the analyte, 
𝑅 > 0. 
The mass transfer in the extraction phase is only controlled by the diffusion and the mass balance 
equation is the same as for other cases explained before. The initial conditions for the binding 
reaction are the same as for DOX-HSA reaction (due to simplifications), however, the initial values 
are different. For the purpose of simulation the matrix concentration was extrapolated until it 
matched to the experimental extraction time profile (the detail has been explained in the ‘results 
and discussion’ section). The initial concentration DOX in the tissue was 25 ng mL-1. The other 
initial conditions were the same as for the SPME extraction in agar gel (static). The boundary 
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conditions at the tissue-extraction phase interface were the same as for other extraction 
conditions described in eq. 2.19. 
 
Mesh: The meshing was user controlled and designed in the same way as for the SPME extraction 
in agar gel (static extraction). 
Study:  Two separate studies were performed like Figure 2.14, except Study-2 did not include 
‘Stationary’ solver required for ‘laminar flow (spf)’ physics. 
2.3.10. LC-MS Characterization of Doxorubicin 
DOX (MW: 543.4 Da) was characterized using a Thermo Ultima 3000 liquid 
chromatographic system coupled to a Quantiva (Thermo Scientific, San Jose, CA) triple quadrupole 
mass spectrometer. The LC-MS method was carried out according to recently published 
literature.65 Briefly, liquid chromatographic separation was carried out using a C-18 (4.6 mm; 
100mm, 5μm) Phenomenex column with mobile phase A (100% H2O +0.1% FA) and mobile phase 
B (100% ACN + 0.1% FA), as stated in the associated literature.65 The instrumental limit of 
quantification (LOQ) under these conditions was 0.1 ppb. 
2.4. Results and discussion 
2.4.1. In-Silico Study of Extraction Kinetics under Static Conditions (in Agar Gel) 
Agar gel is considered as an ideal matrix for static (no convection) extractions without any 
binding matrix. Here, numerical simulations were based on the mass transfer kinetics of analytes 
that take place between the boundary layer of the SPME fiber coating and the sample matrix. The 
mass balance equation can be  derived from eq. (1.8):32 
𝑁 = ∇ ∗ (𝐷∇𝑐) − 𝒖 ∗ ∇𝑐 + 𝑅                    (2.27)                        
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Where 𝑐 is the concentration of the species (mol.m-3), 𝐷 denotes the diffusion coefficient (m2.s-1), 
𝑅 is the amount of any species produced or consumed in the system (mol m-3 s-1), and 𝒖 is the 
velocity vector (m s-1). The flux vector 𝑁  (mol m-2 s-1) is associated with the net change in mass 
transfer at the boundary layer.  
In static extraction conditions for agar gel, 𝑁  is only controlled by diffusion and the binding 
equilibrium which can be expressed by eq. (1.9). 
𝑁 = 𝐷∇𝑐                                            
For solid-coating adsorption kinetics, the flux vector 𝑁  for static extraction in agar gel can be 
expressed as: 
𝑁 (𝑚𝑜𝑙 𝑚  𝑠 ) = 𝑟 − 𝑟                                     (2.28) 
From eq. (2.7) and (2.28), 




      (2.29) 
Eq. (2.29) defines the mass transfer kinetics in static mode for solid coatings. The constant 𝑘  
was experimentally determined based on the assumption that 𝑟  can be considered negligible 
at the start of extraction, since the amount of extract on the fiber is infinitesimally small. In this 
case, eq. (2.29) can be expressed as: 
(𝑚𝑜𝑙 𝑚  𝑠 ) = 𝑘 ∗ [𝐴] ∗ 1 −                        (2.30) 
Experimentally,   can be obtained from the amount extracted on the fiber over time when the 
extraction rate is in the linear regime, which was experimentally observed to occur after 10 mins 
of extraction. Prior to this time point, the amount of extract on the fiber was below the 
instrumental LOQ. Therefore, 𝑘  from eq. (2.30) can be derived as follows: 
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𝑘  ( ) = [ ] ∗( )
                                                       (2.31) 
Once  𝑘  is attained via eq. (2.31), the value of 𝑘  can be obtained from eq. (2.7), followed by 
measurement of the adsorption equilibrium constant K. In this work, the specific surface area per 
fiber was 4.54e-5 (m2), while the saturated amount of DOX extracted per fiber was determined as 
5.1e-09 (mol) (Figure 2.2). The calculated value of γ  for DOX was 1.12E-04 (mol m-2). From eq. 
(2.7), the estimated value of the adsorption equilibrium constant for DOX was ≈468 (m3 mol-1) 
(Table 2.2). Considering these parameters, the extraction kinetics were simulated using 
mathematical models and validated against experimental results. Simulation was performed using 
a 3D model designed in COMSOL Multiphysics 5.2, using the experimental parameters listed above 
to demonstrate the extraction kinetics in agar gel. The calculated results were then compared with 
the experimental extraction time profile. The simulation showed that the equilibrium time for 
static extraction was approximately 80 h, which is in good agreement with experimental results 
(see Figure 2.16).  
 
Figure 2. 16  Comparison of in-silico and experimental extraction time profiles of DOX with an 
initial concentration of 100 ng∙mL-1 in agar gel 
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In-Silico Study of Extraction Kinetics using Agitated Conditions (in PBS). Under agitation, the flux 
vector 𝑁  can be expressed as: 
𝑁 = ∇ ∗ (𝐷∇𝑐) − 𝒖 ∗ ∇𝑐 = 𝑟 − 𝑟                                     (2.32) 
The mass transfer equation for solid coatings is the same as eq. (2.30), except that in this case, the 
flux 𝑁  changes rapidly due to the convection term 𝒖, which enables equilibrium conditions to be 
established at a faster rate in comparison to the rate of equilibrium at static conditions.  
 
Figure 2. 17 Comparison of in-silico and experimental extraction time profiles of DOX, with initial 
concentration of 100 ng∙mL-1 in PBS 
 
Simulated extraction kinetics under agitated conditions forecasted the time to reach equilibrium 






2.4.2. In-Silico Study of Extraction Kinetics under Agitated Conditions in the Presence of 
an HSA Binding Matrix.  
In the presence of a binding matrix, the flux vector 𝑁  is defined by eq. (2.27). The reaction 
term 𝑅 of eq. (2.27) can be derived from eq. (2.12). 
𝑅 = 𝑘 ∗ ([𝐴] ∗ [𝑀] ) + 𝑘 ∗ ([𝐴] − [𝐴]               (2.33) 
Therefore, the flux for analyte in the presence of a binding matrix can be calculated as: 
𝑁 = ∇. (𝐷∇𝑐) − 𝒖. ∇𝑐 − 𝑘 ∗ ([𝐴] ∗ [𝑀] ) + 𝑘 ∗ ([𝐴] − [𝐴] )   (2.34)                                                       
This equation was used calculate extraction time profiles in the presence of a binding matrix are 
as follows: 
= 𝐷∇𝑐 − 𝒖. ∇𝑐 − 𝑘 ∗ ([𝐴] ∗ [𝑀] ) + 𝑘 ∗ ([𝐴] − [𝐴] )       (2.35) 
In order to simulate an extraction time profile in the presence of the HSA binding matrix, the value 
of the binding association constant (𝐾 )  was determined experimentally from Table 2.4 followed 
by using eq. (2.13). This calculated value was used to simulate an extraction time profile in the 
presence of a binding matrix, with good agreement found between simulated and experimental 
results. In this simulation, the value of the dissociation rate constant, 𝑘  with HSA for DOX was 




Figure 2. 18 The X axis represents the total HSA concentration and Y axis is the ration of total DOX 
concentration to free DOX concentration. Initial concentration of DOX was 100 ng∙mL-1 
 
Table 2. 4 Experimentally calculated free DOX concentration at different HSA concentration 
Mtot (mol m-3) Atot (mol m-3) Afree (mol m-3) 
0.15   1.08E-04 
0.3   8.47E-05 
0.45 0.0001841 6.63E-05 
0.6   5.01E-05 
0.75   4.39E-05 
0.9   3.16E-05 
 
𝐾  was calculated from the slope of the linear regression line presented in Figure 2.18, yielding a 
value of 6203 (l mol-1), which agrees with the literature value.47 The mass transfer kinetics of DOX 
in the presence of HSA was progressing faster than without HSA. This is due to the matrix assisted 
(HSA in this case) mass transfer. The equilibrium of DOX-HSA-PBS extraction kinetics was attained 
after approx. 60 min compared to the 82 min observed in DOX-PBS solution. 
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Figure 2. 19 In-Silico comparison of SPME extraction of DOX (100 ppb) in presence of HSA binding 
matrix (0.541 mol m-3) in PBS 
 
The amount extracted at equilibrium with HSA binding matrix was ≈40 ng significantly lower than 
without HSA binding matrix (≈100 ng) considering the same sample volume (1.7 mL) and the initial 
concentration of DOX (100 ppb). This indicates that a substantial amount of DOX was bound to 
HSA matrix. Figure 2.19 shows the in-silico comparison of SPME extraction of DOX in the presence 
of HSA binding matrix.  
In-silico study of DOX in tissue: Given the extraction in tissue matrix occurs under static conditions, 
the kinetics of extraction are calculated using the following static conditions formulae. The mass 
balance equation for tissue can be derived from (2.35) as: 
= 𝐷∇𝑐 − 𝑘 ∗ ([𝐴] ∗ [𝑀] ) + 𝑘 ∗ ([𝐴] − [𝐴] )   (2.36) 
In case of tissue matrix, there are different types of binding matrix components, and it is difficult 























components in the extracellular space of the tissue is one, then the apparent binding constant for 
DOX can be derived from eq. (2.14) as: 
𝐾 = 𝐾 ∗ [𝑀]       (2.37) 
The product of 𝐾 ∗ [𝑀]  in eq. (2.37) is a unitless factor, and a constant for a given matrix. Here, 
[𝑀]  defines the total concentration of different binding matrices. Since DOX has binding affinity 
to DNA, serum albumin, cell membrane, and other binding agents presents in the tissue matrix, 
calculating the true concentration of the binding matrix in the tissue is therefore impractical due 
to the complex nature of the binding mechanism.69,70 Therefore, we consider 𝐾  as an apparent 
binding constant, which can be predicted in a well-defined mathematical model by changing the 
total matrix concentration [𝑀] . As the value of 𝐾  for DOX with HSA matrix has been 
experimentally determined and validated by mathematical simulation (Figure 2.19; in-silico 
comparison of extraction time profile using experimentally determined 𝐾 . Now in eq. (2.37), if 
we change the concentration of total matrix [𝑀]  value of 𝐾  will increase. The trend of the 
extraction time profile with a 3D mathematical model was developed for DOX extraction in the 
tissue matrix under static conditions.  
73  
 
Figure 2. 20 Change of extraction time profile for DOX in tissue with changing the binding matrix 
concentration [𝑴]𝒕𝒐𝒕 
 
These findings indicate that it is possible to determine the apparent binding constant for an 
analyte in a tissue or any complex biological matrix (where multiple binding components are 
present) by developing a well-defined mathematical model and performing all relevant 
experiments to validate it. However, this theoretical approximation is only valid for those 
compounds which bind univalently to the matrix components. The novelty of this concept was the 
experimental and mathematical approach to determine the apparent binding constant 𝐾  for 
DOX in the tissue matrix and the measurement of free analyte  concentration in the tissue matrix. 
The data oprovided by the mathematical simulation simplified the complexities associated with 
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the experimental conditions, particularly when it becomes cumbersome to differentiate the 
binding association constant for each different binding matrix present in the sample. The 
extraction kinetic profiles behaved similarly despite using different matrix concentrations [M] and 






Figure 2. 21  Comparison of in-silico and experimental extraction time profiles of doxorubicin (25 
µg g-1) in homogenized bovine lung tissue 
 
Experimental results from tissue showed that approximately 7 ng of DOX are extracted when 
an initial concentration of 25 µg∙g-1 is spiked into the tissue. Extraction reached equilibrium after 
25 min (equilibration time was herein defined as the time needed for 95% of the total equilibrium 
concentration to be extracted onto the coating), which is reasonable given the high binding affinity 
of DOX for lung tissue components. Simulated results were well-fitted with experimental results 
despite the fact that experimental errors are higher at lower time points due to the proximity of 
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the experimentally extracted amount to LOQ values. For all other studied initial concentrations in 
tissue matrix, the amount of extract at equilibrium were identical (within error) to in-silico 
extracted amounts, while the analytical concentration of the sample was observed in the range 
studied. In-silico results were in agreement with the attained experimental results.65 Finally, the 
free concentration of DOX from lung tissue was estimated from eq. (2.14), yielding a value of 
1.25e-05 (mol m-3) for 25 µg g-1. These results indicate that DOX is heavily bound to the tissue 
matrix, at an estimated binding percentage of 99.97%. The experimentally attained value was very 
close to the value generated by numerical simulations.  
2.4.3. Negligible depletion of free concentration and spatial resolution 
To determine the free concentration of analyte in the presence of binding matrix 
components, negligible depletion of the free concentration surrounding the SPME fiber is 
imperative. Figure 2.9 (a) describes how the free concentration DOX depletes over the time 
around the SPME fiber during static extraction in agar gel. The X axis represents the distance from 
the SPME fiber in millimeter while the Y axis is the concentration of DOX in the sample matrix in 
mol m-3. At the beginning of extraction time profile, the depletion of concentration in the proximity 
of the fiber is higher (the green line graph at 1h). The total length of the X axis represents the 
dimension of the sample matrix which is the diameter of the glass vial (10 mm) used in the 
experiment. From that figure, we can assume that the boundary layer thickness is approximately 
8 mm after 1h of extraction. However, close to the equilibrium (the blue line graph at 82 h) there 
is no gradient of concentration around the fiber. On the other hand, extraction from tissue matrix 
apparently exhibited negligible depletion of the free concentration at equilibrium conditions, as 
seen in Figure 2.9 (b). Therefore, although the C-8 mixed mode SPME fiber enabled significant 
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depletion of the free concentration of DOX at equilibrium, estimated at approximately 60 percent 
of the initial concentration, extraction from tissue matrix apparently exhibited negligible depletion 
of the free concentration at equilibrium conditions. Such a phenomenon is caused by the rapid 
release of DOX from the matrix-bound complex, indicating that the binding matrix and the SPME 
extraction phase compete for DOX. In fact, the binding matrix works as a buffer to maintain the 
free form of DOX surrounding the fiber while it is being extracted onto the extraction phase. It 
should be noted as well that the free concentration of DOX will likely not change in the matrix 
system unless the dissociation rate constants 𝑘  are slow. This also indicates that successive 
extractions from the same place within the sample matrix should not matter particularly if the 
matrix bound fraction of the analyte is significantly higher than that of unbound analyte, as the 
matrix replenishes the free concentration rapidly. Figure 2.9 (c) evidences the spatial resolution of 
the SPME sampling by showing the depleted DOX concentration volume surrounding the fiber at 
equilibrium. This indicates that placing multiple SPME fibers in a small region of sample matrix 
should not interfere in the extraction kinetics. Therefore, experimental results should incur less 
bias relative to the matrix. 
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Figure 2. 22 (a) COMSOL simulation shows the change of DOX concentration in agar gel across a 
line drawn through the center of the SPME fiber at different extraction times. The X axis shows 
the distance from the fiber, and the Y axis represents concentration. The initial concentration was 
0.1 µg∙mL-1 (b) The change in the free concentration of DOX in tissue at equilibrium, indicating that the 
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gradient in concentration is negligible. The initial concentration was 25 µg∙g-1. (c) The spatial resolution of 
the concentration gradient of DOX in tissue across a 2D line cut through the SPME fiber 
 
2.5. Conclusion 
This chapter theoretically studies the extraction dynamics of molecules from bovine lung 
tissue using solid-phase microextraction, further presenting experimental validation of the 
COMSOL simulation models using a well-known chemotherapeutic drug, doxorubicin (DOX) as a 
model compound. In this context, a novel technique was introduced for measurement of free drug 
concentration in bovine tissue homogenate by using biocompatible C-8 mixed mode SPME fiber. 
Also, theoretical studies were discussed and defined to interpret several crucial concepts on mass 
transfer kinetics that take place in tissue matrix. To validate the established mathematical models, 
a novel SPME technique to determine free and bound concentrations from tissue by either in vivo 
or ex vivo sampling was theoretically developed and experimentally established, using DOX. The 
attained experimental results were explained and cross-validated by mathematical COMSOL 
simulations, which described in detail the mass transfer kinetics of DOX in lung tissue matrix. 
Moreover, derived from this primary work, several relevant concepts concerning tissue sampling, 
such as apparent binding constant, spatial resolution, and local depletion, were developed and 
discussed. Of note, the attained results help to shed light on the principle of SPME tissue 
extraction, including in vivo extraction scenarios. As part of this investigation, the unbound free 
concentration of analyte is shown to remain constant when a thin coating SPME fiber is used, as 
the amount of analyte that is transferred to the coating is replaced from the reservoir of analyte 
bound to the tissue matrix. In addition, the presented work represents the first attempt to 
measure free drug concentrations in tissue matrix with the assistance of mathematical models. 
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The key attributes of the herein presented numerical models include estimation of the apparent 
binding constant 𝐾  of DOX in tissue matrix, demonstration of negligible depletion, and spatial 
resolution for multiple ex vivo or in vivo samplings. Here, 𝐾  is defined as a unitless constant 
that describes the binding properties of an analyte in a specific sample matrix; in this work, the 
𝐾  for DOX in bovine lung tissue was estimated as 1252. The value of 𝐾  is difficult to estimate 
experimentally since the total concentration of binding species [M] is unknown in a given tissue 
matrix. This limitation is herein addressed by taking advantage of the mathematical models 
established in this work. Although this study was performed using homogenized tissue, future 
research efforts may include estimation of in vivo free concentrations in the extracellular space of 
tissue matrix. The developed simulation approach thus substantiates that SPME can be used as a 
valuable tool for accurate measurements of free drug concentrations in tissue matrix. Of note, we 
could have selected BSA as a binding matrix to estimate the binding association constant 𝐾   
instead of HSA. However, given that the ultimate goal of this ongoing research concerns future 
implementation of this technique for in vivo determinations in human lung tissue, HSA was herein 
selected as binding matrix. Finally, the output of this article is not only limited to DOX or lung 
tissue, but also paves the way for quantitation of free and conjugated forms of other drugs in any 
complex biological matrix. In fact, this study will allow for exploration of completely new horizons 
in biomedical sciences, such as in vivo monitoring of drug pharmacodynamics in tissue, without 
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There is mounting evidence that solid-phase microextraction (SPME) is a suitable tool for 
extracting lipophilic compounds from tissues in-vivo. In this chapter, we employ SPME to 
investigate the multiphase equilibria of fatty acids in complex samples, such as human serum 
albumin.71,72,73 Fatty acids (FA) are a lipid class that can be readily found throughout the human 
body due to their key role in physiological processes. Some of the major functions of FAs include 
providing a source of energy because of metabolic reactions via β-oxidation in the heart and 
skeletal muscles; serving as key constituents of phospholipids, which provide fluidity and flexibility 
to cell membranes; and as cellular signaling molecules, such as those responsible for reducing 
tyrosine phosphorylation in the insulin receptor substrate (IRS)-I/II. Fatty acids can be supplied to 
the body through diet; and they can also be synthesized in the body via desaturation and 
elongation of dietary FAs, also from carbohydrate catabolism. Linoleic acid (LA) and alpha-Linolenic 
acid (aLA), which are available in different vegetable oils, are the primary precursors of the 
biosynthesis of longer ω-6 and ω-3 polyunsaturated fatty acids (PUFAs), respectively. FAs acquired 
through one’s diet are deposited in the adipose tissue, where they are stored as triglycerides until 
being released into the body through lipolysis.74 ,75 When FAs are released into the blood, they 
strongly bind to human serum albumin (HSA) to be transported to the muscle tissue, and to the 
liver for ketone synthesis. HSA is the most abundant protein in blood plasma, and functions as a 
cargo/or transport vehicle for FAs in addition to controlling oncotic pressure. Furthermore, it is 
unique in that it is able to bind up to 99% of non-esterified fatty acids (NEFAs) under normal 
physiological conditions.76 Excessive abundance of NEFAs in a person’s blood plasma can have 
major consequences for their health; for example,  elevated NEFA levels have been causally linked 
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to obesity and other health-related risks, such as type 2 diabetes mellitus (T2DM), cardiovascular 
diseases, myocardial infarction, and inflammatory diseases like rheumatoid arthritis (RA).75,77,78,79 
Not all FAs adversely affect one’s health, however; some play a central role in ameliorating health 
risks, most notably ω-3 and ω-6 PUFAs. ω-3 and ω-6 PUFAs also play a vital role in the normal 
growth of brains and retinas in newborn humans, as well as functioning as precursors for a plethora 
of signaling lipids with anti-inflammatory properties.80,81,82  
Aside from their immense biological and pathological importance, FAs also play a critical role 
in interaction of human serum albumin (HSA) with other molecules. Many studies have revealed 
that HSA’s affinity to drugs and other endogenous molecules may be modulated by the number of 
FAs bound to the HSA.83,84 This characteristic interplay between FAs and HSA has attracted scientific 
interest in drug development studies.85,11,76 Under normal physiological conditions, almost 99% of 
NEFAs are heavily bound to HSA, with an FA-to-HSA molar ratio of <1. However, there are multiple 
binding sites for FAs on HSA, and the number of FAs that bind to HSA will vary as the FA-to-HSA 
molar ratio changes.87 The binding pattern of FAs to HSA can also be altered due to allosteric 
effects, such as proteins or peptides released by cancerous cells, which compete with specific FA 
binding sites.76 The investigation of FA-HSA binding is therefore important, as it can further develop 
our understanding of their dynamic behavior as a lipid transport mechanism, their role in 
pharmacokinetic and pharmacodynamic (PK/PD) studies of drug molecules, and their regulatory 
function in many physiological reactions. However, the mechanism responsible for FA-HSA binding 
is not as straightforward as the mechanism governing the binding of other small molecules, 
because HSA offers numerous binding sites for FAs. High-resolution X-ray crystallographic analysis 
of HSA-palmitate complexes reveals that there are at least seven FA binding sites heterogeneously 
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distributed across three structurally similar HSA domains.88 Furthermore, recent two-dimensional 
nuclear magnetic resonance (2D NMR) studies of HSA-palmitate complexes have identified at least 
nine FA binding sites in HSA; of these, three have high affinity, one has medium affinity, and the 
others have low affinity.89 Although multiple FA binding sites have been identified and categorized, 
we know of no prior studies that have attempted to determine the binding affinity of FAs to a 
specific site. However, the site-specific binding affinities are variable not fixed.87,90,91 In an attempt 
to understand the complex characteristics FA-HSA binding, Goodman et al. first experimentally 
determined the stoichiometric and site-specific binding constants of long chain FAs to HSA, and 
then applied the Scatchard equation for multiple ligand-receptor interactions.92  
3.2.1. Theoretical approach  
For a multivalent receptor R with b number of binding sites for a ligand L, the stepwise 
stoichiometric equilibria can be formulated as:93 
𝑅 + 𝐿 ⇄ 𝑅𝐿  
𝑅𝐿 + 𝐿 ⇄ 𝑅𝐿  
𝑅𝐿 + 𝐿 ⇄ 𝑅𝐿  




   or, [𝑅𝐿 ] = 𝐾 ∗ [𝑅] ∗ [𝐿] 
𝐾 =
[𝑅𝐿 ]
[𝑅𝐿 ] ∗ [𝐿]
 
 [𝑅𝐿 ] = 𝐾 ∗ [𝑅𝐿 ] ∗ [𝐿] = 𝐾 ∗ 𝐾 ∗ 𝐿  
[𝑅𝐿 ] = 𝐾 ∗ 𝐾 … 𝐾 ∗ 𝐿        (3.1) 
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The number of ligand (L) molecules bound per receptor molecules (R) can be expressed as the 
degree of binding (B) of ligand to receptor at a given ligand concentration, or the saturation 
fraction. B can be expressed as a function of free ligand (Cf = [𝐿]) and total ligand (Ct) and total 
receptor (Cr) concentrations:  
𝐵 =  
( )
=  
   
   
   `    (3.2) 
From stoichiometric equilibrium steps, eq. (3.2) can be formulated as: 
𝐵 =  
[𝑅𝐿 ] + 2[𝑅𝐿 ] + ⋯ +  𝑏[𝑅𝐿 ]
[𝑅𝐿 ] + [𝑅𝐿 ] + ⋯ +  [𝑅𝐿 ]
 
Or,  𝐵 =  ∗
[ ] ∗ ∗[ ] …  ( ∗ ∗… )[ ]
∗[ ] ∗ ∗[ ] …  ( ∗ ∗… )[ ]
     (3.3) 
Eq. (3.3) demonstrates the stoichiometric binding interactions in terms of ligand concentrations.  
In case of site-oriented approach, the total number of site binding constants is determined by 𝑏 ∗
2  number of different binding constants where 2  are independent. For site-oriented 
interactions, 
𝑅 + 𝐿 ⇄ 𝑅 𝐿  
Where, 𝑅 represents the ith binding site of the receptor. For each binding site, eq. (3.2) can be 
formulated as: 
𝐵 =  
𝑘 ∗ [𝐿]
1 +  𝑘 ∗ [𝐿]
 
Then the receptor as a whole, 
𝐵 =  
( )
=  ∑ 𝐵 =  ∑
∗[ ]
 ∗[ ]
      (3.4) 
Eq. (3.4) is defines the site-oriented binding approach for multiple sets of binding sites. A special 
case that is often assumed to be applicable is a system with two classes of binding sites, each with 
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identical invariant affinities that differ from the identical invariant affinities of the other class.94 
Under this circumstances, Eq4 can be simplified as: 








     (3.5) 
Where 𝑏  and 𝑏  represents respective classes; 𝑏 + 𝑏  = 𝑏, and 𝑘  and 𝑘  are corresponding 
site binding constants. Eq. (3.4) and eq. (3.5) are nonlinear and used to study FAs to HSA in terms 
of site-oriented approach. However, interactions between binding sites (cooperation) make it 
difficult to interpret the binding isotherm in terms of site-oriented scrutiny. Therefore, the 
stoichiometric binding constant approach is the appropriate way to investigate FAs binding to 
HSA.94  
3.2.2. Site-specific vs. stoichiometric binding affinities 
 
The principles underlying the stoichiometric and site-specific binding constants are 
illustrated below. If we consider a receptor (R) with two binding sites, b1 and b2, four equilibria are 
established in a site-oriented approach. The corresponding binding constants for the ligand, L, are 
kb1, kb2, kb1,b2, and kb2,b1. If the two binding sites are identical (invariant affinity), there will be one 
site-binding constant, which will be equal to kb1. If the binding sites are not identical, but the 
binding interactions are independent of each other (noncooperative), there will be two site-
binding constants: kb1 and kb2. kb1 is equivalent to kb2,b1, and kb2 is equivalent to kb1,b2 because the 
binding of one site does not interfere with the other. On the other hand, stoichiometric binding 
constants do not distinguish between the intermediates, 𝑅  and 𝑅 ; rather, they comprise both 
constants, kb1 and kb2, in first equilibrium constant. Similarly kb1,b2 and kb2,b1 are incorporated in the 
second equilibrium constant. If the binding sites are not independent, all site-binding constants 
86  
will be different, but the number of stoichiometric binding constants will be the same. As the 
number of non-identical binding sites and their respective cooperativity increases, it becomes 
more difficult to interpret a site-oriented binding approach. In such cases, a stoichiometric binding 
approach is more practical.  
 
 
Figure 3. 1 Schematic diagram of ligand-bivalent receptor binding interactions 
The cooperation among the binding sites can be clearly observed by measuring the stoichiometric 
binding affinities, and the degree of cooperativity is determined by the Hill equation, which is given 
for a single set of binding sites (𝑏) and 𝑘 intrinsic binding constant as follows:95 
𝐵 =  
( ∗[ ])
( ∗[ ])
        (3.6) 
Where 𝑛 is the Hill coefficient, which represents the degree of cooperation between binding sites 
(𝑛 = 1: no cooperation; 𝑛 > 1: positive cooperation; and 𝑛 < 1: negative cooperation). There are 
multiple statistical software programs that use nonlinear curve fitting equations to solve eq. (3.6).96 
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In the present study, we used the GraphPad Prism software tool to determine the apparent binding 
affinity and the Hill coefficient, which determines the cooperation between binding sites. 
3.2.3. Binding constant by Scatchard plot 
The binding constant for a single set of binding sites where all binding affinities are 
considered similar can be measured using a Scatchard plot. In this case, eq. (3.4) can be simplified 
as below: 
= (𝑏 − 𝐵)𝐾        (3.7) 
The binding constant, 𝐾, is the slope and can be measured by plotting  vs 𝐵 (Figure 3.2) 
 
Figure 3. 2  Schematic diagram of Scatchard plot for identical and one-set of binding sites 
If there is cooperation, the slope becomes nonlinear.   




3.2.4. Experimental techniques 
For this study, it is critical to obtain accurate measurements of the free (unbound) 
concentration of FAs (𝐿) in eqs. 4 and 5. However, FAs have very low solubility in aqueous phases, 
which results in experimental difficulties when attempting to accurately measure their free 
concentrations, while also not disturbing the equilibrium between the ligands and receptors.97 
Goodman et al. first studied the binding isotherm of FAs with HSA receptors by using radio-isotope-
labelled FAs to determine the free concentration of FAs. To this end, they partitioned the FAs in a 
water-heptane two-phase system to circumvent the low solubility of FAs. The distribution of free 
FAs between the water and heptane was dependent on their partition coefficients, which were 
known. The free FAs were then collected from the aqueous phase and quantified using a radiation 
detector. The major drawback of this method is the very low solubility of long-chain fatty acids, 
which results in poor quantitative results. Recent studies have more commonly employed 
equilibrium dialysis (ED) and isothermal titration calorimetry (ITC) to study the binding 
characteristics of FAs to HSA.97,98,99,100 However, ED has several shortcomings, such as possible 
analytes loss of analytes to the dialysis interface, its time-consuming nature, and poor quantitative 
results when the free concentration is very low.101  On the other hand, ITC has multiple advantages. 
For example, it is nondestructive, which means that a sample can be reused, and it can measure 
many thermodynamic parameters (e.g., binding affinity, binding enthalpy, and stoichiometry) in a 
single experiment. However, ITC is limited by low sensitivity and requires a high amount of samples; 
therefore, it is commonly considered a complementary method. Another sensitive technique 
capable of measuring the binding affinity of ligand receptors is surface plasmon resonance (SPR), 
wherein the receptor (in this case HSA) is tagged into a gold-coated surface by a covalent linker. 
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The introduction of the ligand changes the surface SPR signal, which is detected by an optical 
detector. Although SPR is highly sensitive, it requires high-purity samples and has high 
experimental costs.102,103 Other possible techniques include 2D NMR analysis, fluorescence 
measurement, and electron paramagnetic resonance; however, these techniques are quite 
sophisticated, require high technical expertise and high purity standards in order to avoid 
background noise, are limited to lower ranges of ligand concentration, and are unable to measure 
the free concentration of FAs in vivo or ex vivo.104,97,105 Recently, Andrew H. Huber et al. developed 
an antibody tagged fluorescent probe that enables the ex vivo measurement of the unbound 
fraction of free fatty acids in blood plasma.106 This technique provides more comprehensive results 
due to its use of ex vivo sampling, and it has been increasingly gaining acceptance by biological 
scientists.106 However, the development of antibody tagged probes is not straightforward, as it 
requires specific antibody probes for specific FAs, which is expensive. To overcome the limitations 
associated with existing separation techniques, we propose the use of solid-phase microextraction 
(SPME) coupled with GraphPad Prism software and Scatchard plot to study the characteristics of 
FA-HSA binding. Developed by Arthur and Pawliszyn in the early 90s, SPME is a separation tool that 
uses a thin layer of extraction phase to separate target analytes based on their affinity for the 
selected coating.31 SPME extracts via free concentration, with its extraction kinetics being 
predominantly driven by diffusion, convection, and binding matrix components. The use of a 
biocompatible extraction phase makes it is possible to separate small molecules from complex 
matrix components, which are essentially large biomolecules. In addition, the small amount 
analyte extracted means the changes to the free concentration will be negligible in the presence 
of binding matrices, which does not the affect the dynamic conditions of the native environment.26 
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Furthermore, calibration can be performed in either equilibrium or pre-equilibrium regimes, which 
significantly shortens experimental time. SPME’s unique characteristics make it an ideal choice for 
measuring the free concentration of analytes in complex biological matrices, both in vivo and ex 
vivo.53 Musteata et al. have already successfully applied SPME in order to explain multiple binding 
interactions between the pharmaceutical drug diazepam and HSA.93 In this article, we apply SPME 
to analyze more complex ligand molecules, such as FAs, and obtain more detailed characterizations 
of the attendant binding characteristics using GraphPad Prism software. We also introduced 
mathematical models in order to illustrate the extraction kinetics of SPME in the presence of a 
binding matrix.  
 
3.2.5. In-silico studies 
 
Simulation can be a great supportive tool in many scientific research areas, as it allows 
researchers to reduce the cost of materials and the amount of time required. Furthermore, 
simulation allows researchers to gain a more in-depth understanding of many complex physics that 
may be difficult to grasp using just common sense. In the present study, we investigate mass 
transfer by developing mathematical models for the kinetics of extractions of FA using SPME with 
a solid coating. In addition to advancing our understanding of the mass transfer of FAs, a validated 
mathematical model can help to reduce the number of experimental steps required for similar 
analytes. Most importantly, when a sample consists of multiple complex matrices (e.g., biological 
tissue), simulations are extremely useful in demonstrating the mass transfer kinetics.26 The 
mathematical models in this research were developed using COMSOL Multiphysics 5.5 simulation 
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software. The extraction kinetics of FAs onto an SPME extraction phase were consistent with the 
adsorption kinetics onto a solid surface. The mathematical equations for mass transfer onto a solid 
extraction phase have been detailed elsewhere in the literature.26 The objective for investigation 
of mass transfer of aLA and LA using mathematical models is to develop well-defined 
computational models which can determine the free concentration of other FAs with similar 
properties. 
 
3.3. Experimental section 
3.3.1. Materials and supplies 
Human serum albumin (HSA, essentially fatty acid free), α-Linolenic acid (aLA), γ-Linolenic 
acid (glA), and chloroform (CHCl3, LC grade) were purchased from Sigma–Aldrich (Oakville, ON, 
Canada), while linoleic acid (LA) and tridecanoic acid were acquired from Cayman chemicals 
(Burlington, ON, Canada). LC-MS-grade methanol (MeOH), isopropyl alcohol (IPA), and water were 
purchased from Fisher Scientific (Mississauga, ON, Canada). C18-coated SPME fibers were kindly 
provided by Millipore–Sigma (Oakville, ON, Canada). Standard stock solutions were prepared daily 
in MeOH from a stock prepared in CHCl3: MeOH (2:1, v/v) and stored at -30 ºC in amber silanized 
vials. 
3.3.2. Measurement of active surface area of SPME extraction phase 
 
BET (Brunauer–Emmett–Teller) is an experimental technique to estimate the active surface 
area of solid material (the theory of BET was explained in chapter 2). The experiment was 
performed to determine the surface area of C-18 fiber by physical adsorption of N2. However, this 
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measurement is a rough estimation, since the pore area is considered for N2 molecule which is 
much smaller than our target analyte. Therefore, we only considered the pores larger than 100 Å, 
which will be able to bind with our target analyte aLA and LA considering their size and shape. It is 
difficult to determine the accurate active surface area for each analyte, since it requires BET 
measurement of that specific analyte which is experimentally not possible (since BET technique 
requires inert gas molecule to calculate specific surface area). Based on this consideration we 
estimated the active surface area of C-18 fiber is app. 2.0 m2 g-1 from Table 3.1. 








Pore Area (m²/g) 
Cumulative Pore 
Area (m²/g) 
2335.820 0.000 0.000 0.000 0.000 
1754.945 0.000 0.000 0.004 0.004 
1329.692 0.000 0.000 0.003 0.008 
1051.384 0.000 0.000 0.002 0.010 
902.340 0.000 0.000 0.003 0.012 
797.678 0.000 0.000 0.003 0.015 
710.907 0.000 0.001 0.002 0.018 
625.532 0.000 0.001 0.007 0.024 
542.974 0.000 0.001 0.004 0.028 
467.420 0.000 0.001 0.006 0.034 
411.828 0.000 0.001 0.009 0.042 
365.583 0.000 0.001 0.008 0.050 
324.368 0.000 0.001 0.010 0.061 
288.465 0.000 0.001 0.013 0.074 
254.816 0.000 0.001 0.033 0.106 
226.426 0.000 0.002 0.054 0.161 
198.395 0.001 0.002 0.120 0.281 
173.434 0.001 0.003 0.186 0.467 
154.157 0.001 0.004 0.256 0.723 
136.106 0.001 0.005 0.420 1.143 
120.213 0.001 0.007 0.475 1.619 
107.587 0.001 0.008 0.428 2.046 
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3.3.3. Measurement of maximum surface concentration of aLA (𝛄𝐬).  
 
This physical parameter is required in order to develop the mathematical model in COMSOL 
Multiphysics. Accordingly, the maximum occupancy of α-Linolenic acid on the surface of the 
extraction phase was measured following the method described below. γ  was determined 
experimentally by performing extractions from initial concentrations of aLA in PBS of 0.01, 0.1, 0.2, 
0.5, 0.75, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 15, and 20 µg∙mL-1 under agitation at 1500 rpm. The active 
surface area of the fiber coating was determined via Brunauer–Emmett–Teller (BET) analysis. 
Therefore, the value of maximum surface concentration (γ ) can be obtained by following eq. (2.5):  
γ =
     
    
=     (2.5)           
To measure saturated aLA amount experimentally, SPME extractions were performed with 
increasing conc. of aLA spiked in PBS (Phosphate Buffer Saline) solution. The extracted amount of 
aLA was plotted against initial concentration in the sample matrix. 
 
























concentration. A plateau was observed at which aLA concentration on the extraction phase 
reached at saturation of monolayer according to Langmuir’s isotherm 
 
The amount of aLA extracted at saturation point is 4683 ng which is equivalent to 1.7e-08 mole of 
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3.3.4. Measurement of the adsorption equilibrium constant (𝑲𝒂𝒅𝒔) for aLA.  
This physical parameter is also necessary in order to develop the mathematical model in 
COMSOL Multiphysics. The equilibrium constant for the adsorption of aLA onto the C18-coated 
SPME fibers was determined by performing agitated extractions at 100 ng∙mL-1 aLA in PBS at 15 
different time points within a 180 min time period, for four independent replicates. After each 
extraction, the fibers were rinsed for 10 s with 400 μL of LC-MS grade water to remove salts and 
nonspecific attachments, and then desorbed for 60 min at 1500 rpm in 200 μL of IPA: MeOH: H2O 
(45:45:10) containing 100 ng/µL of tridecanoic acid as an internal standard. The adsorption 
equilibrium constant, 𝐾   was experimentally determined using following equation:  
Parameters (unit) Value 
Specific surface area (m^2/g) 2.0 
Amount of particle per fiber (g) 4.5E-04 







[A] ∗ (1 − cs/γ )
 
 












1.8𝑒   




2.04e-04 2.49e-07 67.1 
 
3.3.5. Static extraction time profile of aLA in agar gel.  
 
The kinetic profile for the static extraction of aLA was assessed by performing static 
extractions in the absence of a binding matrix. An agar gel solution in PBS (0.8%, w/v) was prepared 
by heating the mixture in a conventional/commercial microwave oven in 1 min increments until 
the agar was completely dissolved. Next, the agar solution was spiked with aLA (100 µg∙mL-1) and 
placed in a water bath at 45°C for 30 min. After the water bath, 1.5 mL aliquots of the solution 
were poured into 2 mL silanized glass vials and allowed to cool at room temperature until they had 
attained a gel-like consistency. Once the solution had gelled, preconditioned SPME fibers were 
inserted into the vials, and static extraction was performed at twenty different time points up to 
210 hours. After each extraction step, the fibers were cleaned with Kim wipes, rinsed with water, 





3.3.6. Agitated extraction time profile of aLA with HSA binding matrix.  
 
Human serum albumin (HSA) was added (20 µM) to PBS (pH 7.4) that had been spiked with 
100 ng∙mL-1 of aLA. To ensure sufficient binding between the analyte and matrix, the solution was 
incubated overnight at room temperature with agitation at 500 rpm. The ensuing extraction profile 
was performed at 500 rpm for up to 300 min at different time points over a 180-minute time 
period. After each extraction step, the above-described fiber treatment procedure was followed. 
3.3.7. Development of mathematical models.  
 
3D simulation models were developed in COMSOL Multiphysics 5.5 software. The purpose 
of 3D models was to implement in vivo in future. Three different mathematical models were 
developed in order to simulate the mass transfer properties in following extraction conditions: 
a) Extraction of FAs in agar gel (static extraction) – the computational model for this extraction 
kinetics is similar to the DOX in agar gel. The mass transfer is controlled by only diffusion. The mass 
balance equation, initial conditions, boundary conditions are same as for DOX in agar gel. The 
physics interfaces for both sample matrix and the extraction phase were ‘transported diluted 
species (tds)’. However, the physical properties of the extraction phase for FAs extraction was C-18 
instead of C-8 mixed mode. Therefore, respective physical parameters different. 
b) Extraction of FAs in PBS solution under agitation – This computational model was similar to 
the DOX extraction in PBS. The mass transfer is controlled by the diffusion and convection. The 
mass balance equation, boundary conditions, initial conditions and the components of the model 
were same as for DOX in PBS under agitated extraction.  
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c) Extraction in PBS with HSA binding matrix – The computational model for this experiment 
was similar to the DOX extraction in PBS-HSA. The mass transfer is controlled by diffusion, 
convection, and matrix components.  
The parameters for extraction kinetics were determined experimentally, with the exception of the 
diffusion coefficient of FAs, which were adjusted into the simulation based on values obtained from 
the literature.107  Because the diffusion coefficient for our target analytes – aLA and LA are not 
available in the literature, however similar compound to aLA and LA are available , such as oleate.  
3.3.8. Binding isotherm of FAs with HSA.  
 
100 mL of 100 μM defatted HSA stock was prepared in PBS, while 500, 1000, 5000 ppm 
stocks of LA and aLA were prepared in MeOH. The LA and aLA stocks were then transferred into 20 
mL silanized amber vials containing 7.5 mL of 20μM HSA solution with FA:HSA ratios of  0.1:1, 
0.25:1, 0.5:1, 1:1, 1.5:1, 2:1, 3:1, 4:1, 4:1, 5:1, 6:1, 7:1, 8:1, 9:1, 10:1, 15:1, and 20:1. The spiked 
solutions were gently agitated at 500 rpm in a shaker for 18h at room temperature to achieve 
equilibration. Subsequently, 1.5 mL aliquots of each sample were transferred into 2 mL silanized 
amber vials, and equilibrium extraction was performed using preconditioned C18 SPME fibers (15 
mm coating length) for 5h at 500 rpm. Following extraction, the fibers were removed and washed 
with 200 μL of LCMS-grade water for 5 s in a vortex to ensure no matrix components remained. 
Finally, desorption was performed in 200 μL of desorption solvent for 1h at 1500 rpm.  
3.3.9. LC-MS/MS quantitation of aLA.  
 
aLA (MW: 278.43 Da) was characterized using either a Dionex UltiMate 3000 UHPLC system 
coupled to a TSQ Quantiva (Thermo Scientific, San Jose, CA) triple quadrupole mass spectrometer, 
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or a Vanquish Flex UHPLC system coupled to a TSQ Vantage (Thermo Scientific, San Jose, CA). 
Chromatographic separation was carried out on a Waters Xselect CSH C18 column (2.1 mm; 
100mm, 2.5μm) using mobile phase A (H2O:MeOH, 3:2 v/v, 0.05% Acetic acid) and mobile phase B 
(MeOH:IPA, 4:1 v/v, 0.05% Acetic acid). MS/MS was operated in SRM mode, and the monitored 
transition was m/z 277.3 > 259.3, which is a dehydration product. The heated-ESI source was 
operated in positive ionization mode under the following conditions: a capillary voltage of 2500 V; 
a vaporizer temperature of 350 °C; and a transfer capillary temperature of 325 °C. These conditions 
enabled an instrumental limit of quantification (LOQ) of 5 ng/mL. The The dehydration product ion 
is considered a non-specific transition ion and therefore not suitable for quantification in a complex 
sample. However, the ionization of long chain FAs is not efficient in ESI (electrospray ionization) 
source. In many cases, derivatization is employed to render these compounds labile and use GC-
MS for quantification. However, within the scope of this study we tried to avoid derivatization in 
order to minimize the loss of the analyte. Since SPME extracts negligible amounts of the analyte 
present in the sample, and the method requires accurate quantification of FAs, we have chosen 
LC-MS/MS analysis using triple quadrupole mass spectrometer. Optimization of the ion source 
parameters was conducted in order to obtain selective product ions (such as loss of hydrogen, or 
carbon dioxide in this case) to a quantification range. However, we have been able to acquire the 
intensity of selective transition ions at barely three order of magnitude for six order magnitude of 





3.4. Results and discussion 
3.4.1. Binding isotherm of FAs with HSA  
The binding isotherm curves for aLA and LA were obtained by measuring free concentration 
at the different FA:HSA ratios detailed in the experimental section. The occupancy of binding sites, 
B, was calculated for each FA:HSA ratio following eq. (3.2), while the total ligand and receptor 
concentrations were known from initial concentration spiked into PBS solution. After binding 
equilibrium was established at a given ligand-receptor ratio, the free ligand concentration, 𝐿, was 
determined via SPME extractions of free ligand.  
 
Figure 3. 4 Binding occupancy, B, isotherm plotted against free ligand concentration of aLA and LA 
with HSA 
 
Figure 3.4 demonstrates how ligand molecules occupy multiple binding sites of HSA receptors as 
the molar ratio of ligands increases. The binding isotherm experiments were followed by a titration 
































were added to the receptors at different molar ratio. The ligand-to-receptor molar ratio range was 
set from 0.1 to 20 with 17 different data points (see Table 3.4 & 3.5). Equilibration was followed by 
SPME extractions to measure free ligand concentrations. Once the SPME extractions were 
completed, the B values for the respective ligand-to-receptor ratios were calculated. At the 
beginning of the isotherm, the B value increased sharply with the addition of ligands, which 
indicates that almost all ligands were bound to the receptor. The isotherm of both ligands reached 
saturation for B≈7 at a ligand-to-receptor ratio of 7:1, where the free concentrations of aLA and LA 
were calculated to be 8.1 and 5.6 μM, respectively (see Table 3.4 & 3.5). After saturation had been 
reached, the addition of more ligands to the receptor did not increase the value of B, which shows 
that HSA receptors have seven specific and high-affinity binding sites. As the ligand molar ratio 
increased, the isotherm curve showed further escalation of the B value, which is presumably due 
to the nonspecific interaction of FAs and the HSA receptor.108  
Table 3. 4  Calculation of B values for aLA-HSA binding isotherm 
Ratio (aLA:HSA) Ext. amt (ng) Free conc. Lf (µM) B 
0.10 9 0.051 0.099 
0.25 16 0.087 0.246 
0.50 19 0.103 0.495 
0.75 25 0.123 0.744 
1.00 37 0.208 0.990 
1.50 63 0.352 1.482 
2.00 96 0.535 1.973 
3.00 145 0.808 2.960 
4.00 238 1.327 3.934 
5.00 362 2.017 4.899 
6.00 651 3.623 5.819 
7.00 1448 8.065 6.597 
8.00 2934 16.337 7.183 
9.00 5689 31.679 7.416 
10.00 8665 48.248 7.588 
15.00 19211 106.970 9.651 
20.00 23450 130.576 13.471 
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Table 3. 5  Calculation of B values for LA-HSA binding isotherm 
Ratio (LA:HSA) Ext. amt (ng) Free conc. Lf (µM) B 
0.10 4 0.023 0.099 
0.25 9 0.052 0.247 
0.50 18 0.100 0.495 
0.75 26 0.145 0.743 
1.50 38 0.211 1.489 
2.00 48 0.264 1.987 
3.00 68 0.378 2.981 
4.00 100 0.551 3.972 
5.00 156 0.860 4.957 
6.00 630 3.484 5.826 
7.00 766 5.600 6.720 
8.00 2860 15.816 7.209 
9.00 7507 41.510 6.925 
10.00 11010 60.877 6.956 
15.00 17705 97.892 10.105 
20.00 23458 129.706 13.515 
 
 
Under normal physiological conditions, the molar ratio of FAs to HSA is usually <1, which indicates 
that almost all FAs are bound to the HSA. Although the binding isotherms for aLA and LA look very 
similar, they have different binding characteristics. These characteristics are explained via 
Scatchard plot below. We used nonlinear curve fitting to obtain the binding affinity constants for 
each ligand to the HSA receptor.  
3.4.2. Measurement of site binding constant using Scatchard plot 
Determination of binding constant was determined from the slop of the Scatchard equation 
(eq8) using nonlinear curve fitting in GraphPad Prism 9.0 software. Experimentally measured of 
free ligand concentrations using SPME were used to calculate B value (see Table 3.4 & 3.5) which 
were used for nonlinear fitting using the model of specific binding with Hill’s coefficient in the 
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software. Obtained results for characteristics binding parameters shown in Table 3.6, whereas 
Figure 3.5 shows the nonlinear fitting of binding isotherms for respective ligands. 
Table 3. 6  Binding parameters obtained using GraphPad Prism software. 
Best-fit values  aLA  LA 
Bmax 7.634 (95% CI: 7.447 to 7.835) 6.849 (95% CI: 6.564 to 7.150) 
h (Hill’s coefficient) 1.098 (95% CI: 1.020 to 1.184) 1.551 (95% CI: 1.264 to 1.907) 
𝐾  (binding dissociation 
constant, μM) 1.263 (95% CI: 1.160 to 1.382) 
0.4695 (95% CI: 0.4109 to 
0.5489) 
Goodness of fit     
Degrees of Freedom 12 12 
R Squared 0.9985 0.9927 
Sum of Squares 0.1666 0.8175 




Figure 3. 5  Curve fitting of aLA and LA with HSA binding isotherm using GraphPad Prism software
 
In Table 3.6, Bmax denotes the highest occupancy of ligands for specific receptor binding 
sites, which was roughly 7 for both ligands. This result indicates that an HSA receptor has seven 
specific binding sites for both ligands. The binding dissociation constant, 𝐾 ,  for aLA and LA was 
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1.26 and 0.46 μM, respectively. In many cases, the binding affinity is interpreted as a binding 
association constant, which is simply the reciprocal of the binding dissociation constant. In this 
case, the binding association constants were 𝐾 = 7.7 𝐸  L/mol and 𝐾 = 2.1 𝐸  L/mol. A 
comparison of the obtained results to those of other methods used to measure similar fatty acids 
yielded comparable results; any discrepancies in the results were due to the fact that the previous 
study focused on ester derivatives of FAs rather than FAs specifically.97 LA had a significantly higher 
binding affinity than aLA, which is presumably due to their structural differences. Specifically, LA’s 
binding affinity is known to increase as the higher number of hydrocarbons.97 The Hill coefficient 
value for LA is higher than for aLA, which indicates that cooperation is more prominent in LA 
binding sites than it is in aLA binding sites. The R2 values also showed very good fit with the 
experimental data, which indicates that the model offers a high level of accuracy. 
3.4.3. Characteristics and cooperativity of binding sites via Scatchard plot 
Scatchard plots for both ligand-receptor binding experiments were constructed using eq. 
2. As shown in Figure 3.6 both positive and negative cooperation were observed for both ligands. 
The upward curve indicates negative cooperation, and the downward curve indicates positive 
cooperation.95 Both isotherms indicated positive and negative cooperation; conversely, the LA:HSA 
binding interaction was more curved, which indicates greater cooperativity than in the case of the 
aLA:HSA complex.   
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Figure 3. 6 Scatchard plot analysis of aLA and LA ligands with HSA receptor 
 
3.4.4. Stoichiometric binding constants 
We determined the stoichiometric binding constants, 𝐾  (stepwise binding reactions), for 
aLA and LA through the nonlinear fitting of experimentally obtained data using the least-squares 
fitting (LSF) method in Microsoft Excel solver. The calculated stoichiometric binding constants are 
summarized in Table 3.7. The accuracy of LSF method depends on the square sum of residuals 
(SSR). In this case, we obtained SSR value app. 0.36.  
Table 3. 7  Calculated stoichiometric binding association constants for aLA and LA using least 
squares fitting of the experimental data. 
ith binding site 𝐾  (aLA-HSA), M-1 𝐾  (LA-HSA), M-1 
1 2.52E+06 4.61E+06 
2 4.42E+06 1.14E+05 
3 1.82E+06 1.96E+08 
4 6.29E+01 2.61E+03 
5 3.78E+09 4.49E+06 
6 1.24E+06 4.41E+08 



















It should be noted that the stoichiometric binding constants calculated using nonlinear regression 
fitting are approximate values. Since there are a lot of free parameters to fit a single curve, this 
may lead to overfitting or high flexibility – which means the graph will nicely fit with experimental 
data but fail to predict unseen values. This can be overcome by generating a lot of experimental 
data. Similar experiment was performed by other researchers for laureate binding study with 
human serum albumin.109,110 In their experiments, they obtained similar graph with plenty of 
experimental data. Besides, the main purpose of this study was to show the cooperativity among 
binding sites. Because, in practical most of the binding studies includes drug-receptor interactions 
where the number of binding sites is very limited and for simplicity, those binding sites are 
categorized into ‘strong’ and ‘weak’ binding sites. Therefore, the number of degrees of freedom is 
reduced to the extent where reliable binding studies are performed using above mentioned 
methods. The sensitivity of the LSF method for LA compound was performed by changing the 
stoichiometric binding constant values presented in Table 3.7. The stoichiometric binding 
constants were determined using nonlinear solver in Microsoft excel followed by eq. (3.3). The 
solver calculates the coefficients (which are stoichiometric binding constants) to obtain the lowest 
square sum of residuals (SSR). The SSR is the residuals between the true B values (experimentally 
determined) and the adjusted B values (calculated by the solver). The obtained SSR value of LA-
HSA study was 0.03 which depends on the accuracy of the experimental results. This results show 
that experimental results were satisfactory. To justify this claim, a sensitivity test was performed 
which is presented in Table 3.8.  In this table, some results of the test analysis were displayed.  The 
test analysis involved the manual changing of stoichiometric constants and observe the desired 
results.  
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Table 3. 8  The  SSR values determined by the solver with respect to stoichiometric binding 
constants 
Lf (µM) B (estimated) B (adjusted) Test-1 (K2*10) Test-2 (K2*100) Test-3 (K3/10) 
0.023 0.10 0.10 0.13 0.35 0.10 
0.052 0.25 0.23 0.44 1.54 0.20 
0.100 0.50 0.50 1.32 2.68 0.34 
0.145 0.74 0.83 2.14 3.05 0.46 
0.211 1.49 1.40 2.89 3.34 0.64 
0.264 1.99 1.87 3.27 3.54 0.81 
0.378 2.98 2.83 3.80 3.90 1.35 
0.551 3.97 4.08 4.30 4.33 2.53 
0.860 4.96 5.32 4.79 4.79 4.17 
3.484 5.83 6.25 6.09 6.09 6.09 
5.600 6.72 6.37 6.48 6.48 6.48 
15.816 7.21 6.67 6.89 6.89 6.89 
41.510 6.92 6.96 6.98 6.98 6.98 
60.877 6.96 7.07 7.00 7.00 7.00       
SSR 
 
0.03 8.38 65.27 1.41 
 
Table 3.8 shows how the SSR values changes in Test runs due to change in stoichiometric binding 
constant values of LA-HSA in Table 3.7. ‘B (estimated)’ indicates the values determined 
experimentally followed by eq. (3.2) whereas ‘B (adjusted)’ are the values adjusted by the solver 
followed by eq. (3.3). It should be noted that, eq. (3.2) requires the value of free concentration of 
analyte to determine B value, On the other hand, eq. (3.3) requires both free analyte concentration 
of analyte as well as the stoichiometric binding constants which are determined by the solver.  
Table 3.7 shows that, the stoichiometric binding constants of LA with HSA are cooperative, such as 
negative cooperation between K1 and K2 which indicates that the second stoichiometric binding 
constant negatively affects the first stoichiometric binding affinity. Therefore, the value of B 
(number of bound analytes per receptor) will decrease compare to no –cooperativity condition. In 
our test analyses (Test-1 and Test-2) in Table 3.8, an increase in B values were observed (highlighted 
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with bold) when the value of K2 was increased one and two order of magnitude. The increase in B 
values in Test-1 and Test-2 indicates that the cooperativity is turning towards the positive direction. 
In Test-3, the value of K3 was decreased one magnitude of order which resulted in lower B values 
(highlighted in bold). This is because K3 shows positive cooperation.  
 To illustrate the cooperativity among binding sites, Klotz affinity model can be plotted 
graphically using stoichiometric binding constants (Figure 3.7). In Fig. 3.7, the Y-axis represents the 
logarithmic value of stoichiometric binding affinity corresponding to the ith binding site on the X-
axis. The trend shows how binding affinity changes according to the binding sites. For positive 
cooperation, binding affinities incline upwards (e.g., the cooperation between the 4th and 5th 
stoichiometric binding affinities for both aLA and LA); for negative cooperation, the binding 
affinities decline (e.g., the 5th and 6th binding affinities of aLA).  
 
Figure 3. 7 Klotz affinity model. The X axis represents the stoichiometric binding constants for ith 
binding stoichiometry and the Y axis represents the respective binding constant. This graph 
indicates how each stoichiometric binding association constant interacts positively (upward) and 



















Figure 3. 8  Nonlinear fitting of binding isotherm of aLA-HSA using least-square fitting (LSF) method 
in Microsoft Excel 
 
Figure 3.8 shows the nonlinear fitting of aLA-HSA binding isotherm considering stoichiometric 
binding equation (eq. 3.3). Experimental B values for 𝐿 over 50μM concentration were not taken 
into account for curve fitting, because those observed B values are considered for nonspecific 
interactions. For nonspecific interactions B value increases slowly with linear gradient. 
3.4.5. In silico studies of SPME extraction kinetics of FAs  
In silico studies were performed to investigate the mass transfer kinetics of FAs onto the 
SPME extraction phase under equilibrium extraction condition. Mass transfer is driven by three 
factors: diffusion, agitation (convection), and any reaction that produces or consumes the target 
in the system. The basic design of the computational models used for investigation of mass 




























L, Free conc. of aLA [μM]
Estimated by LSF Experimental
Experimental B values for 
nonspecific interactions
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chapter 2. Detailed mathematical explanations for these respective models have been provided in 
chapter 2. The primary objective computational models were to develop well-defined 
mathematical models that can be used to study other FAs which are similar in properties, such as 
stearic acid (18:0), oleic acid (18:1), linoleic acid (18:2) and alpha-linoleic acid (18:3) have many 
similar physical properties.  
 
Figure 3. 9  In-silico comparison of extraction time profile for (a) static extraction of 100 ppm aLA 
spiked in PBS-agar gel, and (b) agitated (500 rpm) extraction of 100 ppm aLA in PBS solution 
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Figure 3.9 shows that, in both the static and agitated conditions, around 65 μg out of 150 
μg (100 µg/mL, 1.5 mL) of aLA was extracted at equilibrium. Since there was no binding matrix in 
these extraction conditions, all aLA is considered to be free (the concentration of aLA in this case 
was lower than the CMC value, and silanized vials were used to avoid the nonspecific adsorption 
of FAs to the surface of the sample vial) and measurable based on the 𝑲𝒂𝒅𝒔 value.26 The amount 
of aLA extracted at equilibrium on a solid SPME coating can be defined as the adsorption 
equilibrium constant, 𝑲𝒂𝒅𝒔, which is a thermodynamic parameter that does not depend on the 
properties of the sample matrix or the convection conditions. Figure 3.9 shows that approximately 
the same amount of aLA was extracted using these two extraction conditions and sample matrices. 
The 𝑲𝒂𝒅𝒔 value of ~𝟕𝟎 𝒎𝟑/𝒎𝒐𝒍 for aLA was determined by measuring its equilibrium 
concentration on the solid extraction phase and in the sample matrix. To obtain the surface 
concentration, we determined the active surface area of the extraction phase via BET analysis 
(Section 3.3.2). For the in-silico studies, a 3D mathematical model for the static extraction kinetics 
was first developed using experimentally obtained values, and the convection conditions were then 
applied to simulate the agitated extraction kinetics. The experimentally measured binding affinity 
of aLA to HSA (𝐾 = 7.9𝐸 𝐿/𝑚𝑜𝑙), followed by Scatchard plotting, was used to simulate 
agitated extraction kinetics in the presence of an HSA binding matrix. The results of this simulation 
showed good agreement with the experimental results (Figure 3.10), which validates the accuracy 
and efficiency of the technique used to determine the binding constant of aLA with HSA. Notably, 
the amount of aLA extracted at equilibrium in the presence of an HSA matrix (20 μM) was 37.3 ng 
(approximately 0.4% of the total initial concentration). It should be noted that these mathematical 
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models developed for aLA and LA can be used to determine the free concentration and mass 
transfer properties in blood plasma.  
 
Figure 3. 10  In-silico modeling compared to experimental of extraction-time profile of aLA from 
PBS solution in the presence of HSA (20 μM) with an aLA:HSA molar ratio of (1:1) 
 
3.5. Conclusion 
The binding of FAs to HSA plays a vital role in the transport of fatty acids in the circulation. 
However, this binding interaction is not straightforward since HSA has multiple high-affinity binding 
sites for FAs, which results in multiple binding equilibria under given physiological conditions. This 
binding can be explained using site-oriented or stoichiometric approaches, depending on how the 
interaction takes place with a specific fatty acid. Regardless, the binding effects determine the 
concentration of free fatty acids. Appropriate analytical methods are required to obtain reliable 
and accurate free analyte concentrations, with or without disturbance of the native environment. 



























the appropriate conditions, the binding equilibrium will not be affected by the mass transfer 
kinetics of the extraction phase, which is a key criterion in the study of ligand-receptor binding. In 
this investigation, SPME was able to successfully and efficiently determine the ligand-receptor 
binding characteristics. The binding association constant for aLA was determined according to 
Scatchard plot, which was used to develop mathematical model to simulate the extraction kinetics 
of aLA in the presence of an HSA binding matrix. It should be mentioned that the apparent binding 
constant is not possible to determine followed by site-oriented and stoichiometric approach if the 
binding sites are not independent and they cooperate with each other. The purpose of the 
Scatchard plot is to determine the apparent binding constant, it can not explain the dynamics of 
the binding characteristics like the other two approaches – site specific binding and stoichiometric 
binding. The results of the in-silico comparisons were satisfactory, which demonstrates the 
usefulness of mathematical models in validating SPME experimental data. In addition, the 
developed mathematical models can be applied to in-silico investigations of similar interactions 
between ligands including lipids and HSA receptors, thereby reducing time, effort, and cost. The 
presented results illustrate principles of non-exhaustive microextraction, specifically those of 
SPME, from a highly bounding matrix. Moreover, they advance our understanding of how this 
technique can be used to obtain information about multiphase equilibria in complex systems, as 
well as how to optimize microextraction conditions and interpret SPME data involving matrix 





Chapter 4: Summary and future perspectives 
This study demonstrates the dynamics of mass transfer kinetics on SPME in complex 
biological samples, such as blood plasma, solid tissue. In chapter 2, a well-known 
chemotherapeutic drug, doxorubicin (DOX) was chosen as a model drug, while bovine lung tissue 
was selected as model matrix. DOX is frequently used as a local chemotherapeutic agent for cancer 
therapy and is currently under pre-clinical trial for treatment of human lung cancer through in vivo 
lung perfusion (IVLP). In this regard, a novel analytical technique to determine free and bound 
concentrations from tissue by either in vivo or ex vivo sampling is demanded. In this study, we 
addressed a novel SPME technique for measurement of DOX from bovine lung tissue by direct 
sampling. 
In these investigations, a model analyte doxorubicin (DOX) was spiked into homogenized 
tissue matrix at transient and equilibrium extraction conditions, with subsequent assessment of 
obtained experimental results by an in-silico approach using mathematical models developed in 
COMSOL Multyphysics. In-silico studies were performed based on transported diluted species (tds) 
and reaction engineering (re) modules from COMSOL Multiphysics, using the same conditions as 
those used to attain experimental results. To determine the apparent binding affinity of DOX to the 
tissue matrix which contains multiple binding species, the experimentally determined binding 
affinity of DOX with human serum albumin (HSA) was considered to simplify the mathematical 
calculations. Here, the value of the binding affinity was considered for single binding site and 
adjusted by fitting the experimental results with the mathematical models. The developed 
mathematical model allows for measurements of free drug concentrations inside tissue matrix and 
facilitates calculations of local depletion of DOX by a solid SPME coating. Results of the 
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investigations indicate that local depletion of the free form of DOX, even at the kinetic stage, is 
negligible for tissue extraction, as the release of the heavily bound analyte (over 99% binding to 
tissue matrix) is very rapid, thus easily compensating for the loss of the drug to the SPME coating. 
This indicates that the dissociation rate constant of DOX from lung tissue components is very rapid; 
therefore, the mass transfer of drug to the fiber coating via free from is very efficient. Our results 
also indicate that thin coating SPME fibers provide a good way to measure drug distribution after 
dosing, as extractions via thin coating SPME fibers do not affect the free concentration of drug, 
which is responsible for drug distribution in tissue. 
This thesis studies the dynamics of solid phase microextraction extraction in tissue with 
the presence of a binding matrix, providing further experimental validation of the theoretical 
findings and mathematical models. In this context, the presented work is introduced as a novel 
technique for measurement of free drug concentration in biological tissue via biocompatible solid-
phase microextraction (SPME). In addition, the presented theoretical studies greatly contribute to 
the literature on SPME by discussing and defining several crucial concepts for in vivo SPME 
sampling, an emerging technique with great potential in bioanalysis.  
Moreover, derived from this primary work, many important concepts in tissue sampling, 
such as apparent binding constant, spatial resolution, and local depletion, were developed and 
discussed. The results of this line of investigation help to shed light on the principles of SPME tissue 
extraction, including in vivo extraction, by demonstrating that when a thin coating SPME fiber is 
used as extraction phase in tissue matrix, the unbound free concentration of analytes in the 
sampling area remains constant as analytes transferred to the coating are rapidly replaced from 
the reservoir of analytes bound to the tissue matrix. Despite its higher extraction capacity, the 
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SPME probe is herein shown to behave similarly to an electrochemical probe, allowing for 
monitoring of drug concentrations at particular locations and enabling measurements of drug 
distribution following dosing in tissue, while additionally facilitating multicomponent 
determinations at the same time. 
The conclusions from this thesis are not limited to only DOX or lung tissue, but also paves 
the way for quantitation of free and conjugated forms of other drugs in any complex biological 
matrix. In fact, this study will allow for exploration of completely new horizons in biomedical 
sciences, such in vivo monitoring of drug pharmacodynamics in tissue, without the need for costly 
and invasive correlative investigations, such as determinations in surrounding biofluids and 
biopsies.   
In chapter 3, SPME technique was employed to investigate the binding characteristics of 
fatty acids (FA) to human serum albumin (HSA) have been garnering increased attention due to the 
importance of FAs in numerous in clinical and biological fields. In that study, binding characteristics 
of two long-chain FAs—linoleic acid (LA; FA 18:2) and alpha-linoleic acid (aLA; FA 18:3, n-3) with 
HSA, was investigated followed by binding isotherm studies. HSA has multiple binding sites for FAs, 
and these binding sites are involved in a complex and dynamic binding equilibrium with FAs. The 
binding dynamics changes with initial concentration of FAs and their length. In this study we 
explained these complex binding interactions in terms of site-oriented and stoichiometric 
approaches. It is very important to understand these binding characteristics to determine the free 
concentration of FAs, because the correlation between the free concentration of and matrix 
components are nonlinear. Computational models were developed to determine free 
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